The QualityStocks Daily Wednesday, November 14th, 2018

Today's Top 3 StockMarketWatch

StocksToBuyNow (ASCK) +63.33%

StockMarketWatch (UGAZ) +59.54%

MarketBeat (NYNY) +53.93%

The QualityStocks Daily Stock List

Grupo TMM, S.A.B. (GTMAY)

Amigo Bulls, Stockhouse, Zacks, CapitalCube, YCharts, Wallet Investor, Last10k, TradingView, Penny Stock Tweets, Marketbeat, The Street, OTC Markets, Penny Stock Picks, VentureLine, and Stockwatch reported earlier on Grupo TMM, S.A.B. (GTMAY), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Grupo TMM, S.A.B. is a Mexican Maritime-management transportation and logistics Company. Grupo TMM operates together with its subsidiaries in Mexico and it operates in four segments. These are Maritime, Logistics, Ports and Terminals, and Warehousing. Grupo TMM is based in Mexico City, Mexico and the Company lists on the OTC Markets’ OTCQB.

Grupo TMM provides maritime transportation services. This includes offshore vessels that provide transportation and other services to the Mexican offshore oil industry. In addition, the Company provides tankers that transport petroleum products in Mexican waters; parcel tankers that transport liquid chemical and vegetable oil cargos from and to the United States and Mexico; and tugboats that provide towing services at the port of Manzanillo, Mexico.

As of March 31, 2018, Grupo TMM operated through a fleet of 39 vessels. These include product and chemical tankers, harbor tugs, and varied offshore supply vessels.

Grupo TMM also provides dry bulk carriers that transport unpackaged commodities, including steel between South America, the Caribbean, and Mexico. Moreover, the Company provides ship repair services through two floating drydocks. Grupo TMM 6also offers logistics services; logistics network analysis; logistics information process design; intermodal transport; and supply chain and logistics management.

Furthermore, the Company provides port agent services to vessel owners and operators in Mexican ports; and warehousing and bonded warehousing facility management services. Additionally, Grupo TMM operates the Tuxpan, Tampico, and Acapulco port facilities. It also offers product handling and repackaging; local pre-assembly; container maintenance and repair; and inbound and outbound distribution to automobile manufacturers and retailers.

In late October, Grupo TMM reported its financial results for Q3 2018. 2018 Q3 results include Accumulated Operating Profit of $1,166.2 million, a Debt decrease of $296.4 million, and $2,238.8 million Stockholders’ Equity.

Mr. José F. Serrano, Grupo TMM Chairman and Chief Executive Officer, said, “As a result of its proven experience Grupo TMM has continued adapting to the new condition of national and international markets, taking advantage of its effective client diversification strategy, cost optimization and revenue improvement. We have also developed new strategies to improve performance in each business unit, and exploit the gradual energy sector reactivation in México…”

Grupo TMM, S.A.B. (GTMAY), closed Wednesday's trading session at $1.35, even for the day, on 700 volume with 4 trades. The average volume for the last 3 months is 1,836 and the stock's 52-week low/high is $0.589/$1.779.

chart

Valens GroWorks Corp. (MYMSF)

Stockhouse, MicroSmallCap, Penny Stock Hub, Stockwatch, Morningstar, Investor Place, Capital Cube, Proactive Investors, MarketWatch, GuruFocus, Investing News, Street Insider, Infront Analytics, New Cannabis Ventures, Market Screener, Streetwise Reports, Wallet Investor, Barchart, 4-Traders, and Dividend Investor reported on Valens GroWorks Corp. (MYMSF), and today we choose to highlight the Company, here at the QualityStocks Daily Newsletter.

Valens GroWorks Corp. is a licensed, vertically integrated provider of cannabis products and services. The Company’s focus is on different proprietary extraction methodologies, distillation, cannabinoid isolation and purification, and associated quality testing. Valens GroWorks has three wholly-owned subsidiaries located in and around Kelowna, British Columbia. The Company’s corporate office is in Kelowna. Yesterday, Valens GroWorks began trading, at market open, on the OTCQB® under the ticker symbol "MYMSF".

Valens GroWorks specializes in vertical integration, extraction processing, as well as setting industry standards. The Company cultivates and creates premier cannabis extracts in the Okanagan area of British Columbia. Everything Valens does is backed by science – from seed to final sale.

The Company’s products/services include extracts and oils, analytical testing, and a medical and recreational focus. Its three subsidiaries are Valens Agritech (VAL), Valens Labs, and Valens Farms.

Valens Agritech (VAL) holds a standard processing and standard cultivation license class under the Cannabis Act. Furthermore, VAL has a supply agreement with Canopy Growth Corporation under their wide-ranging CraftGrow distribution network. Valens Labs is an ISO 17025 accredited cannabis testing lab. It provides sector-leading analytical services. Valens Labs has partnered with Thermo Fisher Scientific to develop a Centre of Excellence in Plant Based Science.

Valens Farms is in the process of becoming a purpose-built facility in compliance with European Union (EU) Good Manufacturing Practices (GMP) standards. This will ensure that the product from this facility can be exported anywhere globally where cannabis is nationally legal for medical or adult usage purposes.

Today, Valens GroWorks announced that it entered into a multi-year Extraction Services Agreement with Harvest One for cannabis extraction and value-added services. With this Agreement, Harvest One's subsidiary, United Greeneries, will ship bulk quantities of dried cannabis to Valens GroWorks over an initial three-year term.

Valens will receive and process the cannabis on a fee for service basis into bulk resin or other cannabis oil derivative products. Additionally, Valens GroWorks will conduct research and development (R&D) services for Harvest One to support their product line development. This includes health and wellness products, beverages, vape pens, and nutraceuticals using cannabis oil derivative products. 

Valens GroWorks Corp. (MYMSF), closed Wednesday's trading session at $1.0981, up 0.74%, on 40,725 volume with 81 trades. The average volume for the last 3 months is 220,328 and the stock's 52-week low/high is $0.784/$2.71.

chart

Clean Coal Technologies, Inc. (CCTC)

InvestorsHub, Stockhouse, Insider Financial, StockNewsUnion.com, Stock Invest, InvestorPoint.com, Small Cap Exclusive, Marketbeat.com, Investors Hangout, and StocksTrade reported on Clean Coal Technologies, Inc. (CCTC), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Clean Coal Technologies, Inc. is an emerging growth coal technology enterprise. The Company holds patented process technology and other intellectual property (IP) that converts raw coal into a cleaner burning fuel. Its trademarked end products, "Pristine™" coals, are considerably more efficient, less polluting, more cost-effective, and provide more heat than untreated coal. OTCQB-listed, Clean Coal Technologies has its headquarters in New York, New York.

The Company’s clean coal technology may decrease approximately 90 percent of chemical pollutants from coal. This includes Sulfur and Mercury. As a result, this resolves emissions issues affecting coal-fired power plants.

Its technology deals with extraction of the volatiles in liquid form from lower ranking coals. Upon the moisture being removed from the targeted coal, the liquid volatiles are used by way of an “absorption” process to fill the pores of the coal that has been dehydrated.  More liquid volatiles are used via an adsorption process to coat the coal.

The result is a significant improvement in the coal ranking through increased caloric content (BTU’s), and a stable low moisture feedstock for power generation. Removing moisture lessens shipping costs by weight and the delivery of less volume of higher ranking coals to meet the requirements of the end user. Moreover, increasing the coal ranking improves the market price and salability of coal.

Clean Coal Technologies’ Pristine M technology is a patented, low-cost coal dehydration technology. The Pristine M process starts with the extraction of volatile material in liquid form from lower ranking coals.

The Company has its Pristine-SA technology. This is a development stage technology designed to eliminate 100 percent of the volatile material in feed coal. In addition, Clean Coal Technologies has its legacy technology, Pristine™. The design of it is to remove moisture and volatile matter (VM), as per client-specified requirements.

In October of 2017, Clean Coal Technologies announced the signing of a Memorandum of Understanding (MOU) with the School of Energy Resources, University of Wyoming. The emphasis of the MOU is to further develop the performance and commercial potential of the Company’s pioneering coal-beneficiation technology. Clean Coal Technologies’ products provide solutions for coal users involved in power generation, steel, and coal-to-gas or coal-to-liquids projects.

Clean Coal Technologies, Inc. (CCTC), closed Wednesday's trading session at $0.12, down 0.25%, on 232,275 volume with 31 trades. The average volume for the last 3 months is 326,155 and the stock's 52-week low/high is $0.059/$0.289.

chart

Digipath, Inc. (DIGP)

SmallCapVoice, SECFilings.com News, Otcstockexchange, Whisper from Wall Street, SmallCapStockPlays, The Wall Street Transcript, CFN Media Group, Promotion Stock Secrets, Cannabis Financial Network News, Wallstreetbuzz, DSR News, Investor News Source, StockRockandRoll, PennyStockLocks.com, TheMicrocapNews, AddictivePennyStocks, PricelessPennyStocks, PennyStockRumors.net, and Real Pennies reported earlier on Digipath, Inc. (DIGP), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Listed on the OTCQB, Digipath, Inc. is an independent cannabis testing and media organization. The Company supports the cannabis industry’s best practices for reliable testing, education, and training, and brings unbiased cannabis news coverage to the cannabis industry. Digipath’s two business units are Digipath Labs and TNM News Corp. Digipath is based in Las Vegas, Nevada.

The National Marijuana News (TNMNews) is the Company’s unbiased cannabis news site and talk radio show. Its emphasis is on the political, economic, medicinal, and cultural dimensions of the medicinal and recreational marijuana industry. Digipath Labs is the cannabis testing subsidiary of the Company.

Digipath Labs is working to set the industry standard for testing all types of cannabis-based products using Food and Drug Administration (FDA)-compliant laboratory equipment and proprietary Standard Operating Procedures (SOP) to ensure product safety and efficacy.

In 2015, Digipath opened its first state-of-the-art cannabis testing lab, Digipath Labs, in Las Vegas, Nevada. Its flagship cannabis analytical testing laboratory in Las Vegas helps safeguard patient safety and provide cannabinoid and terpenoid potency data that can be used to match specific products to medical conditions.

Digipath Labs has been chosen as the laboratory testing service provider for The Clinic Nevada, LLC. The Clinic has many retail and cultivation locations in Colorado and Illinois. The Clinic Nevada is a licensed cannabis cultivator, producer, and dispenser located in Las Vegas, Nevada. At present, Digipath tests products coming out of The Clinic Nevada's production facility branded as "The Lab".

This past September, Digipath announced that it entered into a joint venture (JV) with Mr. Don Ashley, an experienced real estate developer and cannabis entrepreneur, to establish and operate a cannabis testing laboratory in California. The JV, Humboldt Botanical, LLC, will conduct business under the name "Digipath Botanical Testing". It will launch Digipath's entry into the largest cannabis market in the U.S.

With this JV agreement, Mr. Ashley will contribute up to $2 million to fund the build-out and equipping of the testing laboratory. Digipath will be responsible for managing and supervising the daily operations of the laboratory.

The new testing laboratory will be part of a larger, three-building cannabis industrial park. The expectation is that the industrial park will include a research and development (R&D) facility, an oils/concentrate manufacturing center, a health and wellness center, a distribution and processing facility, a tissue culture nursery, a hemp clothing outlet, and coffee bistro. 

Digipath, Inc. (DIGP), closed Wednesday's trading session at $0.1395, up 7.31%, on 125,008 volume with 30 trades. The average volume for the last 3 months is 92,520 and the stock's 52-week low/high is $0.101/$0.589.

chart

eWellness Healthcare Corp. (EWLL)

StockHideout, Penny Stock Prodigy, InvestorsHub, Stockhouse, and 4-Traders reported on eWellness Healthcare Corp. (EWLL), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

eWellness Healthcare Corp. develops a telemedicine platform. The platform is for providing Distance Monitored Physical Therapy programs. These programs are for pre-diabetic, cardiac, and health challenged patients through contracted physician practices and healthcare systems. eWellness Healthcare has its headquarters in Culver City, California.

The Company has launched PHZIO. The design of this Physical Therapy Telemedicine platform is to extend and scale a physician’s practice. eWellness Healthcare is the first physical therapy telemedicine company to provide insurance reimbursable real-time distance monitored treatments.

The Company’s business model is to license the PHZIO platform to any Physical Therapy (PT) clinic in the United States and/or have large-scale employers use its PHZIO platform as a completely PT monitored corporate wellness program.

eWellness Healthcare’s PHZIO extends a traditional practice online. The principal features of the PHZIO platform include video treatment protocols, real-time patient monitoring, patient induction forms, a patient video journal, and post treatment evaluations. Principal features also include integrated billing, patient metrics, and user administration & customization. PHZIO also scales a practice’s billable rates and provides tools to make growing a business easier.

Concerning the Patient Dashboard, the PHZIO Dashboard enables clients to login securely to access prescribed treatment protocols. PHZIO is user-friendly and highly reliable to operate for PT and Patient. Additionally, it is a complete on-line PT telemedicine intervention system.

eWellness Healthcare has launched its new patient lead generation platform, LeadRemedy.com. Lead Remedy increases a Practices’ social networks reach through tapping into the employees of the practice and their social circles.

In March, eWellness Healthcare announced that it signed an Advisory Agreement with Fintech Global Consultants (FGC) to assist the Company in completing Blockchain adaptation across the $30 billion physical therapy and $8 billion wellness markets with new advanced healthtech tools.

Last month, eWellness Healthcare announced the advancement of its sales and marketing efforts to various state employee groups and agencies starting with the State of Florida.

Mr. Darwin Fogt, eWellness Healthcare Chief Executive Officer, said, “We are very excited to introduce our PHZIO treatment platform that could offer up to a 50 percent savings ($174 million annually) on PT/OT costs to the State of Florida. We anticipate participating in existing PT services Requests for Proposals (RFP’s), along with a direct dialog with state officials for the provisioning of customized PT/OT and corporate wellness service plans.”

In addition, in April, eWellness Healthcare announced it is developing the first tokenized physical therapy payment system for insurance companies, large scale self-insured corporations and their insured members. Fintech Global Consultants will assist eWellness Healthcare in completing the Blockchain and tokenized payment system.

eWellness Healthcare Corp. (EWLL), closed Wednesday's trading session at $0.1025, up 1.49%, on 260,942 volume with 25 trades. The average volume for the last 3 months is 568,025 and the stock's 52-week low/high is $0.045/$0.1449.

chart

Cavitation Technologies, Inc. (CVAT)

CRWEFinance, MicroStockProfit, Hotstocked, Stock Preacher, Stockwire, ActivePennyStock, PennyStocks24, PennyStockWatchman, UndiscoveredEquities, Beacon Equity Research, MicrocapVoice, CRWEWallStreet, DrStockPick, and PennyOmega reported on Cavitation Technologies, Inc. (CVAT), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Cavitation Technologies, Inc. designs and manufactures state-of-the-art, flow-through, devices and systems. Furthermore, it develops processing technologies for use in edible oil refining, renewable fuel production, expeditious petroleum upgrading, algae oil extraction, alcoholic beverage enhancement, and water treatment. Established in 2007, Cavitation Technologies is based in Chatsworth, California.

Desmet Ballestra Group, S.A. has been the Company’s strategic partner since 2010. Cavitation Technologies has commercialized its patent-pending CTi Nano Neutralization® process. It provides the refiners of edible oils and fats significant yield improvements, major cost savings, as well as environmental benefits.

Desmet Ballestra Group has partnered with Cavitation Technologies to market this ground-breaking technology globally to large-scale facilities. Desmet Ballestra Group is the foremost worldwide solutions provider for the edible oil and fats and biodiesel industries.

Cavitation Technologies is a pioneering leader in processing liquids, fluidic mixtures, emulsions, and suspended solids. As an add-on to its existing neutralization systems, the Company’s patented NanoReactor™ enables refiners to considerably lessen processing costs and environmental impact. This is while also improving yield.

The Company’s core technology includes the use of hydrodynamic cavitation. Cavitation can be of different origins. These origins include acoustic (typically, ultrasound-induced), hydrodynamic or generated with laser light, accelerated particles, an electrical discharge or steam injection.

Cavitation’s technologies can be applied to a number of other fluid-processing industries, which will benefit from increased yields, reduced processing costs, and improved quality. The Company has filed patent applications related to edible oil refining, algal oil extraction, renewable fuel production, alcoholic and non-alcoholic beverage processing and enhancement, water treatment and purification, and petroleum upgrading.

In November, Cavitation Technologies announced it received a purchase order from Desmet Ballestra Group. Cavitation’s Nano Reactor™ is to be installed at a new vegetable oil refinery with daily capacity of 900 metric tonnes per day (MTPD). This represents the first purchase order Cavitation received in China. The expectation is that the system shipment will be completed in the Company's fiscal Q2 2018.

Cavitation Technologies, Inc. (CVAT), closed Wednesday's trading session at $0.037, up 11.45%, on 64,250 volume with 4 trades. The average volume for the last 3 months is 97,761 and the stock's 52-week low/high is $0.0149/$0.059.

chart

Golden Predator Mining Corp. (NTGSF)

OTC Markets, Stockhouse, Junior Mining Network, Barchart, Gold Investment Letter, Penny Stock Hub, and The Street reported on Golden Predator Mining Corp. (NTGSF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Golden Predator Mining Corp. acquires and explores for mineral properties in the U.S. and Canada. The Company concentrates on its district scale, orogenic gold-in-quartz 3 Aces Project in the Yukon. Incorporated in 2008, the Company previously went by the name Northern Tiger Resources, Inc. It changed its name to Golden Predator Mining Corp. in April of 2014. Golden Predator Mining has its corporate office in Vancouver, British Columbia.

The 3 Aces Project is 357 km2 (35,700 hectares), 100 percent owned (subject to underlying royalties), and is a high-grade gold project (Orogenic Gold Model). It includes at least 6 mineralized areas. These are all positioned within and along favorable stratigraphic and structural zones, which extend more than 35km along trend.

A number of mineralized veins have been discovered to date. Many have visible gold occurrences. The 3 Aces Project hosts the two highest grade surface outcrops discovered so far in the Yukon.

The initial emphasis of the 2018 exploration program will be to drill wide-spaced diamond core holes into the major shear zones and folds associated with the postulated anticline. The work will start in the Central Core Area and move along strike and down dip following already identified gold-bearing structures.

In addition, the Company holds 100 percent of the advanced Brewery Creek Project in the Yukon. The Brewery Creek Mine is operated by Golden Predator Mining Corp.

The Brewery Creek Mine is 55km east of Dawson in the northwestern region of the Yukon. The target at this Project is an intrusion related gold deposit. Gold is the commodity at Brewery Creek.

Earlier this month, Golden Predator Mining reported the results of 42 Reverse Circulation (RC) drill holes completed in 2017 at the 3 Aces Project. Initial drilling is reported from the Diamonds Zone along with the Hearts/Clubs Corridor.

The Company stated that all areas encountered encouraging results and will see continued drilling this year. The final 43 RC holes completed in 2017 will be reported separately.

Gold mineralization ranging from anomalous to high grade was encountered in 30 of the 42 holes drilled across the Central Core. This includes the Hearts, Clubs, and the Diamonds Zones.

High-grade quartz veins continue to be encountered along with a growing abundance of disseminated and stockwork occurrences. These two kinds of mineralization are integral to Golden Predator Mining’s conceptual geological model.

In addition, this month, Golden Predator Mining reported results of 43 Grade Control drill holes at the 3 Aces Project. This includes the highest gold assays returned so far from drilling on the project.

The design of the drill holes was to investigate close-space variability in three different areas of the Spades Zone. This is to prepare for resource delineation drilling across the Central Core Area later in 2018.

The close-spaced Grade Control drilling was completed in three areas. All of these areas are now considered to be part of the larger central Spades Zone. Significant gold mineralization was encountered in 39 of the 43 holes.

Golden Predator Mining Corp. (NTGSF), closed Wednesday's trading session at $0.1967, up 1.24%, on 87,942 volume with 55 trades. The average volume for the last 3 months is 67,955 and the stock's 52-week low/high is $0.19/$0.743.

chart

Bravada Gold Corp. (BGAVF)

Gold Investment Letter and Real Pennies reported on Bravada Gold Corp. (BGAVF), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Bravada Gold Corp. is a Nevada-focused exploration and development company. It has a large portfolio of high-quality properties. These properties cover a range of development stages. This is from early-stage exploration to advanced-stage exploration and pre-development. Bravada Gold has its corporate headquarters in Vancouver, British Columbia. The Company lists on the OTC Markets’ OTCQB.

Bravada Gold retains residual working or royalty interests. It explores for precious metals in well-established gold trends in one of the world’s best gold jurisdictions. Currently, five of the Company’s Nevada properties are being funded by partners. In total this includes earn-in work expenditures of up to $6.5 million and payments to Bravada Gold of up to +$3.0 million in cash and shares. Bravada holds a royalty on eventual barite production on its Shoshone Pediment Project.

Concerning the North Lone Mountain and South Lone Mountain projects, plans have not been finalized for Bravada Gold’s two claim groups. Nevertheless, Nevada Zinc continues to expand the footprint of zinc mineralization on its claims towards Bravada’s South Lone Mountain claims. Should Nevada Zinc complete the purchase of these claims, Bravada will retain a royalty on base and precious metals.

Pertaining to its Wind Mountain project, Bravada’s plan is to drill-test for high-grade “Hishikari-type” gold/silver vein mineralization beneath the existing disseminated resource at Wind Mountain. Regarding the SF property, Bravada plans to drill-test for high-grade “Carlin-type” gold mineralization at this property.

Recently, Bravada Gold announced that it received, subject to posting a reclamation bond, approval of its drilling permit from the U.S. Forest Service for its Quito Gold property. The permit allows four sites to be drilled at the Quito Extension target this year. Multiple holes can be drilled from these sites. The Quito Property is positioned along the Austin Gold trend in central Nevada.

Moreover, Bravada Gold, via its wholly-owned U.S. subsidiary Bravo Alaska, Inc.,  and Yamana Gold, Inc., via its wholly-owned U.S. subsidiary Meridian Minerals Corp. (collectively Yamana), have agreed to amend the earn-in agreement for the Quito Property.

The amendment will eliminate a "Claw-back" provision that allowed Yamana Gold to re-acquire a 51 percent ownership in Quito after earn-in by Bravada Gold of a 70 percent working interest (WI) in the property with all other terms remaining constant. As consideration for the amendment, Yamana Gold will receive 1,000,000 common shares in Bravada Gold and warrants to purchase 1,000,000 common shares at CDN$0.15 for a period of three years.

Bravada Gold Corp. (BGAVF), closed Wednesday's trading session at $0.044, up 12.82%, on 247,145 volume with 8 trades. The average volume for the last 3 months is 25,687 and the stock's 52-week low/high is $0.039/$0.14.

chart

CreditRiskMonitor.com, Inc. (CRMZ)

MarketWatch, Zacks, InvestorsHub, Barchart, Marketbeat, Morningstar, CapitalCube, Last10k, Glassdoor, 4-Traders, Business Wire, Stockhouse, YCharts, and Marketwired reported earlier on CreditRiskMonitor.com, Inc. (CRMZ), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

CreditRiskMonitor.com, Inc. provides interactive business-to-business (B2B) Internet-based services for corporate credit and procurement professionals internationally. Essentially, the Company is a financial risk analysis and news service for credit, supply chain, and also financial professionals. Additionally, it offers solutions that can help ease private company financial risk assessment. CreditRiskMonitor is headquartered in Valley Cottage, New York. The Company lists on the OTC Markets’ OTCQX.

CreditRiskMonitor’s main expertise and emphasis is on financial analysis of public debt and equity companies. Its service offers comprehensive commercial credit reports and financial risk analysis covering public companies around the world. The core of the Company’s fundamental service is its 96 percent accurate FRISK® score, formulated to evaluate bankruptcy risk in public companies within a 12-month window. The FRISK® score incorporates several important risk indicators. This includes crowdsourced click patterns of credit professionals and other subscribers.

Other features of CreditRiskMonitor’s fundamental service include Moody’s and Fitch bond agency ratings; timely email alerts on news, risk and ratings changes; key financial ratios and trends; the Altman Z”-Score; the PAYCE™ score, and the FRISK® Stress Index, among other features. The Company also provides Institutional Risk Analytics counterparty quality scores and financial data from the Federal Financial Institutions Examination Council call reports covering banks. Moreover, CreditRiskMonitor provides company background information, and trade payment reports, and also public filings on millions of companies in the U.S.

Last week, CreditRiskMonitor reported that Revenues were $3.48 million and $10.33 million for the three and nine months ended September 30, 2018, respectively. This represents an increase of 2.8 percent and 3.7 percent over the comparable periods the year prior.

For the same periods, Loss from Operations was roughlyly ($45,300) and ($521,000), respectively. This is in comparison to roughly ($4,800) and ($439,500) for the comparable 2017 periods. Cash and Cash Equivalents at the end of the nine-month period decreased $128,700 to $8.61 million in comparison to the 2017 year-end balance of $8.74 million.

CreditRiskMonitor.com, Inc. (CRMZ), closed Wednesday's trading session at $2.05, even for the day. The average volume for the last 3 months is 566 and the stock's 52-week low/high is $1.39/$2.74.

chart

AdvanSource Biomaterials Corp. (ASNB)

Money Morning, S.A. Advisory, TopPennyStockMovers, Zacks, and Nebula Stocks reported earlier on AdvanSource Biomaterials Corp. (ASNB), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

AdvanSource Biomaterials Corp. is an ISO certified materials technology company listed on the OTCQB. Specialists in polyurethane technologies, the Company provides an array of material formats for use in long and short-term implants and disposable products. In essence, AdvanSource is a leading developer of advanced polymer materials for a broad range of medical devices. AdvanSource Biomaterials is based in Wilmington, Massachusetts.

The Company’s materials have a history of use in short and long-term implant applications. These include stents, artificial heart valves, VADs, catheters, guidewires, and introducers. AdvanSource serves the medical device and pharmaceutical market.

Its expertise lies in the synthesis and formulation of polymeric materials with a wide spectrum of physical and chemical properties. These materials possess unique characteristics including biocompatibility and biodurability. They can be tailored for specific properties, including lubricity and antimicrobial formats.

AdvanSource’s business model leverages its proprietary materials science technology and manufacturing expertise. This is to expand its product sales and royalty and license fee income. Markets served include orthopedics, cardiovascular, drug delivery, endoscopy, neurology, urology, spine, interventional radiology, peripheral vascular, ENT, gastroenterology, oncology, and diabetes management.

AdvanSource’s biomaterials are used in devices designed for treating a broad spectrum of anatomical sites and disease states. The Company’s products include ChronoFlex AL; ChronoFlex AR; ChronoFlex C; ChronoPrene; ChronoSil; ChronoThane P; ChronoThane T; HydroMed; HydroThane; and PolyBlend.

AdvanSource manufactures specialty hydrophilic polyurethanes that primarily sell to customers as part of exclusive arrangements. The Company’s technical services include coating capabilities to help with prototype development.

Its ChronoFlex AL is a family of biodurable aliphatic polycarbonate-based thermoplastic urethanes. The design of these is to overcome surface degradation such as stress-induced microfissures.

AdvanSource’s PolyBlend is a family of very soft, aromatic polyurethane elastomeric alloys. These can be used as a substitute for natural rubber or latex in numerous applications. The Company’s HydroMed is a series of ether-based hydrophilic urethanes with first-rate adhesive and cohesive properties.

AdvanSource Biomaterials has a strategic alliance with Medibrane Ltd. Medibrane is a foremost Israeli coating technology company. The Strategic Alliance provides for technology collaboration, development, and commercialization of medical coatings using AdvanSource’s material technologies in collaboration with Medibrane’s coating and surface modification technologies and enhancements.

AdvanSource Biomaterials Corp. (ASNB), closed Wednesday's trading session at $0.07525, up 14.71%, on 1,000 volume with 1 trade. The average volume for the last 3 months is 30,895 and the stock's 52-week low/high is $0.0281/$0.10.

chart

Dthera Sciences (DTHR)

Penny Stock Hub, Market Screener, 4-Traders, OTC Markets, Dividend Investor, MarketWatch, Investors Hub, Barchart, Internet Bull Report, Stockopedia, New to the Street, TradingView, Simply Wall St, and Digital Journal reported on Dthera Sciences (DTHR), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Dthera Sciences is a digital therapeutics company based in San Diego, California. It works to improve Quality of Life (QoL) and reduce anxiety in residents with Alzheimer’s, Dementia, and isolation. The Company’s focus is on developing unique digital QoL therapies for neurodegenerative diseases and oncology. Dthera Sciences’ lead product is ReminX (regarding Reminiscence Therapy for Anxiety Reduction). Dthera Sciences’ shares trade on the OTC Markets Group’s OTCQB.

ReminX is an artificial-intelligence (AI)-powered digital therapeutic. The design of ReminX is to reduce anxiety and improve QoL in patients with Alzheimer's disease and Dementia. ReminX has completed a successful clinical trial with the University of California San Diego showing its effectiveness as a scalable form of Reminiscence Therapy.

Reminiscence Therapy (RT) is talking about or reviewing recognizable memories. This is through looking at photos, and hearing or discussing the familiar stories related to them. ReminX is a digital therapeutic. It takes personalized stories and delivers a treatment called Reminiscence Therapy to ease stress. Family members use the ReminX application (app) to upload photos and provide narration. Seniors pick up their ReminX tablet to watch stories from their own and their loved one’s lives. ReminX is available on IOS and Android.

Dthera Sciences has launched ReminX™. This is an AI-powered consumer health product. The design of it is to digitally deliver Reminiscence Therapy to individuals suffering from Alzheimer's and other dementias, as well as from social isolation. This digital therapeutic device is the first to focus on the care of the elderly.

Dthera Sciences announced this past August that the U.S. Food and Drug Administration (FDA) granted Breakthrough Device designation to Dthera’s development-stage product, DTHR-ALZ. If granted approval, DTHR-ALZ would become the first non-pharmacological prescription treatment for the symptoms of Alzheimer's disease. The intention of DTHR-ALZ is to be a prescription digital therapeutic that will deliver Reminiscence Therapy to patients with Alzheimer's disease. The device will use AI to automatically optimize the therapy based on diverse forms of biofeedback from the patient.

Recently, Dthera Sciences announced the appointment of Amir Kalali, M.D. to its Board of Directors. Dr. Kalali will also be Chairman of the Company's Scientific Advisory Board. Dr. Kalali is recognized around the world as a foremost innovator at the intersection of life sciences and technology, advising companies on building the future of their business at the board level or as a strategic advisor. Previously, Dr. Kalali was the Global Head of the Neuroscience Center of Excellence at Quintiles, now known as IQVIA.

Dthera Sciences (DTHR), closed Wednesday's trading session at $6.00, even for the day. The average volume for the last 3 months is 3,104 and the stock's 52-week low/high is $3.95/$25.00.

chart

Flux Power Holdings, Inc. (FLUX)

Tip.us, StockMister, PennyPickAlerts, Joe Penny Stocks, Liquid Tycoon, Super Hot Penny Stocks, Super Nova Stock Picks, WePickPennyStocks, Winning Penny Stock Picks, The Wall Street Transcript, Stock News Now, PennyStocks24, Catalyst IR, Penny Stock Pick Alert, Penny Stock Pick Report, PennyStockMoneyTrain, RisingPennyStocks, Lebed, Wall Street Grand, and Greenbackers reported earlier on Flux Power Holdings, Inc. (FLUX), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Flux Power Holdings, Inc. is a developer of advanced lithium batteries for industrial applications. This includes its first-ever UL 2271 Listed lithium-ion "LiFT Pack" forklift batteries. The OTCQB-listed Company develops and markets advanced lithium-ion energy storage systems (batteries) founded on its proprietary battery management system (BMS) and in-house engineering and product design. Flux Power Holdings is based in Vista, California.

Flux Power’s storage solutions deliver improved performance, extended cycle life, and greater return on investment (ROI) than legacy solutions. The Company’s products include advanced battery packs for motive power in the lift equipment, tug and tow, and robotics markets, portable power for military applications, and stationary power for grid storage. Applications include Motive Power, Portable Power, and Stationary Power. Motive Power includes Lift Pack - Class III Walkie Trucks and Lift Pack - Tug & Tow Pack.

Concerning Portable Power, Flux Portable Packs consist of lithium-ion battery cells that are managed and operated by its proprietary Battery Management System (BMS), all contained in lightweight, strong, and easily maneuvered cases. The design of Flux’s LiFT Pack solution is for walkie pallet jack forklifts, extensively used in warehouses and depots, on trucks, and at retail locations. The Company has developed a 72 volt, 400 Ah battery pack to power electric aviation ground support equipment, initially baggage tow tractors using the same proprietary technology found on the LiFT Pack line for small forklifts.

Regarding the Flux battery model: LiFT-24V, it offers up to a 5 times longer lifespan andup to a 25 percent longer run time. In addition, it offers higher sustained power during every work shift. It is maintenance-free and fewer batteries are required for multi-shift applications.

This past September, Flux Power Holdings announced it secured a $350,000 order to provide Flux LiFT Pack X Series 48 volt, 600 ampere hour batteries and chargers for a Midwest automotive parts supplier. The customer is converting from propane power to leading European electric counterbalance trucks powered by Flux Power’s ground-breaking lithium-ion batteries.

In October, Flux received a $0.3M order for additional airport GSE batteries from an existing international airline customer. The Company stated that this customer is expected to place significant additional orders in calendar 2019. It also stated that two other major airlines are piloting its packs and Flux anticipates them starting orders in calendar year 2019.

Flux Power Holdings recently reported results for its fiscal 2019 Q1 ended September 30, 2018 (Q1 ‘19). Q1 ’19 Revenue increased more than tenfold to $1.84M in comparison to Q1 ’18 revenue of $0.15M. It increased 67 percent sequentially from Q4’18 revenue of $1.1M.

Flux Power Holdings, Inc. (FLUX), closed Wednesday's trading session at $1.90, up 4.40%, on 3,065 volume with 13 trades. The average volume for the last 3 months is 5,480 and the stock's 52-week low/high is $0.253/$3.35.

chart

Escalon Medical Corp. (ESMC)

Stock Twits, Dividend Investor, Wallet Investor, Morningstar, OTCPicks, MarketWatch, Stockhouse, last10k, Equity Clock, Wall Street Resources, FeedBlitz, PennyToBuck, 4-Traders, and InvestorsHub reported earlier on Escalon Medical Corp. (ESMC), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

Escalon Medical Corp. specializes in the development, marketing, and distribution of ophthalmic diagnostic imaging and surgical products. The Company is working to grow its ophthalmic business through further developing and diversifying its product offering by way of internal development programs, strategic partnerships, and the acquisition of technology to best leverage its distribution capabilities. Escalon Medical is based in Wayne, Pennsylvania. The Company has research and development (R&D), manufacturing, and distribution operations in New Hyde Park, New York; New Berlin, Wisconsin; and Stoneham, Massachusetts.

Escalon Medical mainly markets to teaching institutions, hospitals, and eye surgery centers. In 2000, the Company acquired Sonomed, Inc. Since then, through acquisition, product divestitures, partnerships, and product development, it has grown and expanded its product offerings. Sonomed, Inc. and Escalon Medical Imaging are wholly-owned subsidiaries of Escalon Medical Corp.

Escalon Medical’s products include an array of ophthalmic ultrasound, digital imaging and photography, and image management systems. The Company’s products also include surgical products, including intraocular gases, fiber optic light guides and sources, and other surgical vitreoretinal instruments. All of its ophthalmic products are branded as Sonomed Escalon. Furthermore, Sonomed Escalon maintains certification for compliance with ISO1385 Quality Management Systems for Medical Devices.

Sonomed Escalon provides ultrasound, digital photography, as well as image management systems. Sonomed Escalon Rx products include mydriatics/cyclopegics; diagnostic supplies; anesthetics/combo products; antibiotics, steroid combination; injectable dyes, surgical products, and office products.

Sonomed Escalon offers its Vu Pad regarding Ophthalmic Ultrasound. This is a new class of ophthalmic ultrasound versatility. It is configurable with B-scan, A-scan, UBM or any combination. Surgical solutions offered also include vitreoretinal gases and devices. Its diagnostic solutions include AXIS image management; ophthalmic ultrasound; mobile vision analysis; adaptive refractor; perimetry; digital imaging, and tonometry.

Pertaining to tonometry, Sonomed Escalon has its “diatom IOP measuring device.” This involves measuring IOP via the eyelid on sclera with no corneal contact. It quickly provides accurate IOP reading independent of corneal thickness. Moreover, it is ideal for cases where standard tonometry cannot be employed. It is handheld and user-friendly. No anesthesia is required and there is no need to remove contact lenses, no need for sterilization, and no patient discomfort or anxiety.

Escalon Medical Corp. (ESMC), closed Wednesday's trading session at $0.18, down 9.91%, on 37,200 volume with 9 trades. The average volume for the last 3 months is 7,072 and the stock's 52-week low/high is $0.108/$0.36.

chart

Zynex, Inc. (ZYXI)

Tip Ranks, Proactive Investors, Insider Financial, Zacks, FeedBlitz, SmallCapVoice, Daily Markets, SmarTrend Newsletters, BUYINS.NET, FNNO Newsletters, 4-Traders, TaglichBrothers, Smarter Analyst, The Street, Insider Monitor and Barchart reported previously on Zynex, Inc. (ZYXI), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Zynex, Inc. is a medical technology company headquartered in Englewood, Colorado. It specializes in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, neuro diagnostics, cardiac and blood volume monitoring. Additionally, the Company is developing a new blood volume monitor (non-invasive Blood Volume Monitor, CM-1500) for use in hospitals and surgery centers. Zynex lists on the OTC Markets’ OTCQB.

Zynex’s product lines are completely developed, Food and Drug Administration (FDA)-cleared, and commercially sold around the world. The Company engineers, manufactures, markets, and sells its own design of medical devices in three subsidiaries.

Zynex NeuroDiagnostics develops devices for EMG and EEG diagnostic purposes in the neurology clinic markets. Zynex Medical is a provider of electrotherapy products for home use. Zynex Monitoring Solutions develops products for cardiac monitoring for use in hospitals.

Zynex believes that its non-invasive Blood Volume Monitor, CM-1500, will be the first device to provide an indication of fluid balance and blood loss in the operating room or potential post-surgical internal bleeding in recovery. The Company markets and sells its own design of electrotherapy medical devices used for pain management and rehabilitation.

Zynex also markets and sells its proprietary NeuroMove device designed to help recovery of stroke and spinal cord injury patients. The design of the NeuroMove™ device is to assist stroke survivors in regaining movement using the brain's ability to rewire itself, also known as "neuro-plasticity".

New products in Zynex’s portfolio include JetStream Hot/Cold Therapy, Aspen LSO Backbracing and Comfortrac cervical traction. All of these products are targeted at treating acute and chronic pain without side-effects.

In October, Zynex announced that it obtained a U.S. utility patent for its Blood Volume Monitor Device. Mr. Thomas Sandgaard, the inventor, assigned the patent to Zynex's subsidiary, Zynex Monitoring Solutions.

Last week, Zynex reported financial results for its Q3 ended September 30, 2018 and a one-time special cash dividend to its shareholders.

Mr. Thomas Sandgaard, Chief Executive Officer, said: "I am pleased to report revenue of $8.1 million in the third quarter with net income of $2.6 million or $0.08 per diluted share. Adjusted EBITDA was $3.0 million, and the quarterly revenue was 19 percent higher than the third quarter of 2017. Revenue was up 7 percent from the $7.6 million recorded in the second quarter of 2018. Orders grew 30 percent compared to the third quarter of 2017 and were 10 percent higher than the second quarter of 2018. Our cash on hand increased to $8.1 million at the end of the third quarter.”

Zynex, Inc. (ZYXI), closed Wednesday's trading session at $3.13, down 2.19%, on 10,777 volume with 21 trades. The average volume for the last 3 months is 22,972 and the stock's 52-week low/high is $1.10/$5.50.

chart

The QualityStocks Company Corner

Earth Science Tech, Inc. (ETST)

The QualityStocks Daily Newsletter would like to spotlight Earth Science Tech, Inc. (ETST).

Earth Science Tech, Inc. (OTCQB: ETST) today announced that it has commenced filming of its direct response television (DRTV) media campaign with mega-entrepreneur Kevin Harrington’s award-winning As Seen On TV production company. The film will include an interview with a customer whose life was positively changed by ETST’s High Grade Full Spectrum Cannabinoids. Also today, texamining how he company was featured in a report by Financialnewsmedia.com examining how alternative medicinal uses and applications continue to be a fast-growing segment in the medical marijuana community and CBD-based solutions are at the forefront of the growth.

Earth Science Tech, Inc. (ETST) is an innovative biotechnology company operating in the fields of hemp cannabinoid (CBD), nutraceutical, pharmaceutical and medical device research and development. Earth Science Tech offers the highest purity and quality, full-spectrum, high-grade hemp CBD (cannabidiol) oil on the market. Made using the supercritical CO2 liquid extraction process, the company’s CBD oil is 100 percent natural and organic. Earth Science Tech has partnered with the University of Central Oklahoma and DV Biologics Laboratory to conduct research and development projects that scientifically support and advance the healthcare benefits of its high-grade hemp CBD oil.

Earth Science Tech Inc. currently has three wholly owned subsidiaries focused on developing its role as a world leader in the CBD space and expanding its work in the pharmaceutical and medical device sectors. These subsidiaries include:

  • Earth Science Pharma, Inc., which is committed to development of low cost, noninvasive diagnostic tools, medical devices, testing processes and vaccines for sexually transmitted infections and/or diseases. Earth Science Pharmaceutical CEO and chief science officer Michel Aubé is leading the company’s research and development efforts. The company’s first medical device, MSN-2, is a home kit designed for the detection of STIs, such as chlamydia, from a self-obtained gynecological specimen. Earth Science Pharma is working to develop and bring to market medical devices and vaccines that meet the specific needs of women.
  • Cannabis Therapeutics, Inc. (“CTI”), which is poised to take a leadership role in the development of new, leading-edge, cannabinoid-based pharmaceutical and nutraceutical products. CTI is invested in research and development to explore and harness the medicinal power of cannabidiol. The company holds a provisional application patent for a CBD product that is focused on developing treatments for breast and ovarian cancers.
  • KannaBidioiD (“KBD”) provides a wide variety of products geared toward the recreational space of cannabis. KBD’s unique Kanna and CBD formulation is sold and distributed in CBD-infused edibles and vapes/e-liquids products. Kanna and CBD synergistically enhance one another, providing optimal relaxation, an uplifting sensation, enhanced focus and the added benefit of assisting with nicotine reduction therapy.

Earth Science Tech celebrated a significant, developmental year during 2017 by sharing its achievements in a condensed end-of-year report. Among the report’s highlights are the implementation of a development plan for the coming three years, which includes expanding into Canada and opening new manufacturing and shipping facilities. Of particular interest is the acquisition of Canna Inno Laboratories Inc., a company headquartered in Montreal, Quebec, Canada, which gives Earth Science Tech access to Canadian government grants offered to innovators in the pharmaceutical industry. ETST has also launched development of proprietary prophylactic therapies utilizing cannabidiol (CBD) to treat various forms of breast cancer.

In October 2017, ETST announced it is cooperating with the Clinique SIDA Amité (AIDS Friendship Clinic) for a mini-clinical trial, the last trial needed before the MSN-2 device, designed for the detection of STIs, enters molecular diagnostic trials. And in November 2017, the company began pre-launch human trials on a new CBD formula to fight against the U.S. opioid epidemic. The new formula, expected to decrease cravings and the negative effects of withdrawal in addicts, is based on industrial hemp CBD mixed with a known natural ingredient proven to help increase dopamine levels. ETST’s medical devices will first be launched in Vietnam, Djibouti and Morocco while the company awaits regulatory permission to enter the North American market.

The company expects to up-list to the OTCQB in early 2018, which management believes will attract well-funded institutional investors and pave the way to becoming the next billion-dollar-in-capitalization company on the OTC markets. Other highlights include completion of the company’s Scientific Advisory Council with a team of recognized scientists, the launching of several CBD-infused edible products and entry into the medical devices market through collaborative partnerships.

Earth Science Tech has signed a collaborate agreement with Laboratories BNK Canada, a private laboratory that will conduct the clinical studies necessary for MSN-2 medical device-related services to meet regulatory requirements. ETST has confirmed the MSN-2 device’s ability to detect chlamydia, and is working to validate similar results for gonorrhea, both highly infectious diseases that often have permanent consequences for patients. ETST will also add testing for trichomoniasis and a complete body fluid panel to detect the different serotypes of the human papillomavirus (HPV) that causes cervical cancer. These additions will help the company create sales opportunities in the global market for diagnostic testing of STDs that Transparency Market Research has indicated will grow to $108 billion by 2019.

Cannabis Therapeutics is in the development stage of two cannabinoid-based pharmaceutical drugs and three cannabinoid-based nutraceutical products targeting a variety of ailments such as anxiety, depression, triple negative breast cancer, and fatty liver disease, among others. Research into the benefits of the non-psychoactive cannabinoid molecules found in the cannabis plant is supported by ETST’s International Application for Provisional Patent titled “Cannabidiol Compositions Including Mixtures and Uses Thereof,” which was filed on October 8, 2015. Cannabis Thera’s R&D efforts are concentrated on developing CBD-based drugs and nutraceutical products and in working to integrate the CBD molecule with existing generic drug molecules to create more efficient medications with fewer and less severe side effects. A report in Hemp Business Journal predicts the CBD consumer market will grow to $2.1 billion by 2020, while other industry experts expect an increase to almost $3 billion by 2021. A recent report by Statista projects the U.S. consumer market for cannabinoid-based pharmaceuticals could reach $50 billion by the year 2029.

The management team at Earth Science Tech brings decades of invaluable experience to the nutraceutical, dietary supplement field as well as the life sciences sectors. Nickolas S. Tabraue, who serves as the president, director and chief operating officer, is an industry veteran with extensive knowledge of supplements, retail management, customer service and sales expertise. He is joined by CEO and CSO Dr. Michel Aubé, a microbiologist whose scientific research in sexually transmitted infections, cancer and stem cell biology has been widely published in several prestigious medical journals. Sergio Castillo, chief marketing officer, and Gabriel Aviles, chief sales officer, bring a wealth of marketing and sales experience to Earth Science Tech, which is complemented by Issa El-Cheikh, Ph.D., and his 25 years in the international finance, accounting, planning and execution of large scale transactions in the public and private sectors.

Earth Science Tech’s products include CBD, a natural constituent of hemp oil derived from hemp stalk and seed. EST offers CBD in the form of vitamins, minerals, herbs, botanicals, personal care products, homeopathies, functional foods and other products delivered in such forms as capsules, tablets, soft gels, chewables, liquids, creams, sprays, powders and whole herbs. Earth Science products can be found at retail stores throughout the United States and are available for purchase through the internet.

Earth Science Tech, Inc. (ETST), closed the day's trading session at $1.04, up 7.22%, on 22,229 volume with 63 trades. The average volume for the last 3 months is 114,926 and the stock's 52-week low/high is $0.421/$2.45.

Recent News

chart

Net Element (NASDAQ: NETE)

The QualityStocks Daily Newsletter would like to spotlight Net Element (NETE).

Net Element, Inc. (NASDAQ: NETE) today reports its financial results for the third quarter ended September 30, 2018, and provides an update on recent strategic and operational initiatives. The call will also be webcast live from https://edge.media-server.com/m6/p/bnctmpfp. Following completion of the call, a recorded replay of the webcast will be available on the www.netelement.com/en/ir website.

Net Element (NETE), is a global financial technology and value-added solutions group that supports electronic payments acceptance in an omni-channel environment spanning across point-of-sale, e-commerce, and mobile devices. Net Element operates a payments-as-a-service transactional model and value-added services platform for small to medium enterprises in the U.S. and selected emerging markets. Internationally, Net Element’s strategy is to leverage its omni-channel platform to deliver flexible offerings to emerging markets with diverse banking, regulatory and demographic conditions. Net Element was ranked as one of the fastest growing companies in North America on Deloitte’s 2017 Technology Fast 500 ™ and South Florida Business Journal’s 2016 fastest growing technology companies.

Net Element believes the future of global commerce is being revolutionized as consumers quickly migrate toward omni-channel shopping utilizing mobile devices, desktop, and online services. Net Element’s all-in-one payment solutions support and unify a whole range of applications through a single, robust platform, allowing global onboarding and support for multiple payment methods.

With an eye on emerging markets, Net Element is pursuing growth opportunities and footholds in a number of industries. The company’s most recent application of its technology is to the cannabis industry, which is paced to hit $591 million and could increase 40 times in the next four years. This rampant growth also creates heightened need for smooth transactions between merchants and consumers. Payment processing and compliance for the cannabis industry has become increasingly complex, and Net Element’s Unified Payments subsidiary is addressing the challenges by offering a compliant, seamlessly integrated payment solution that makes it simple to transact.

Net Element has also launched a blockchain-focused business unit that will develop and deploy blockchain technology-based solutions. Net Element expects the new division to create a decentralized crypto-based ecosystem that will act as a framework for an unlimited number of value-added services, connecting merchants and consumers in a seamless, economically efficient transaction. This new business unit intends to also identify and invest in unique projects that decentralize and disrupt the payment processing industry by combining blockchain technology and real-world applications with talented development teams, strong fundamentals and addressable markets large in size.

“We believe that we’re at the dawn of a new evolution where additional digital payment methods are being introduced,” Net Element CEO Oleg Firer, says. “Introduction of our division focused on blockchain as part of the NASDAQ-listed entity will add transparency and compliance assurance to our investors as well as provide access to deploy value-added services to over 20 million electronic commerce clients that are currently part of Net Element’s growing network.”

Net Element clients are treated to customized solutions that provide the flexibility needed to keep up with customers. Among the services offered are mobile payment apps that accept payments anywhere, anytime; cloud-based solutions built to increase productivity and enhance revenue for clients and partners; marketing solutions that turn lookers into buyers; and business analytics that make it easy for clients to monitor business metrics, engage with customers and compare the competition. Its multi-channel platform combines e-commerce, offline, point-of-sale, comprehensive back office tools, mobile point-of-sale, credit scoring and customer interaction in one powerful platform-as-a-service technology.

Net Element owns and operates a global mobile payments and transactional processing provider, TOT Group, Inc., with the following subsidiaries:

  • Unified Payments – An award-winning, customized mobile billing and payments solution, recognized by Inc. Magazine as the No. 1 Fastest Growing Company in America in 2012.
  • Digital Provider – A leading provider of SMS messaging and mobile billing solutions.
  • Aptito – A next-generation, all-in-one, cloud-based restaurant management and point-of-sale payments platform using wireless technology.
  • Payonline – A fully integrated, processor agnostic electronic commerce platform.

Net Element is ranked No. 418 on Deloitte’s 2017 Technology Fast 500™ list of North America’s 500 fastest growing technology, media, telecommunications, life sciences and energy tech companies. Net Element grew 190 percent. The company’s chief executive officer, Oleg Firer, credits the company’s progression to organic growth in its North America Transactions Segment, specifically the success of its Unified Payments brand, which focuses on value-added payment acceptance solutions for small to medium enterprises in the United States.

“The Deloitte 2017 North America Technology Fast 500 winners underscore the impact of technological innovation and world class customer service in driving growth, in a fiercely competitive environment,” said Sandra Shirai, vice chairman, Deloitte Consulting LLP and U.S. technology, media and telecommunications leader. “These companies are on the cutting edge, and are transforming the way we do business.”

Net Element’s suite of application performing interfaces (APIs) and connectors power commerce for businesses of all sizes through multi-channel platforms, all-in-one digital solutions, and end-to-end encryption of cardholder data utilizing tamper resistant hardware that ensures integrity and simplifies security.

Net Element’s corporate team is led by director and CEO Oleg Firer, who is responsible for the overall vision, strategy and execution of the company’s mission of powering global commerce. He is joined by CFO Jeffrey Ginsburg, CPA, and Steven Wolberg, who is the company’s chief legal officer and secretary. Each corporate officer brings a unique blend of leadership, vision, experience and creative energy to the company.

From mobile payments and value-added transactional innovations such as Digital Provider and Aptito to e-commerce and retail payment transaction processing brands like Payonline and United Payments, Net Element is transforming the online and mobile experience.

Net Element (NETE), closed the day's trading session at $6.38, up 5.63%, on 147,608 volume with 685 trades. The average volume for the last 3 months is 286,273 and the stock's 52-week low/high is $3.50/$33.51.

Recent News

chart

Sugarmade, Inc. (SGMD)

The QualityStocks Daily Newsletter would like to spotlight Sugarmade, Inc. (SGMD).

Sugarmade, Inc. (SGMD) was featured today in a report by CannabisNewsWire examining how, with Canada’s decision to decriminalize cannabis nationwide and the 2018 U.S. Farm Bill’s provision to potentially make industrial hemp and hemp-derived cannabidiol (CBD) legal nationwide, the cannabis CBD product sector is gaining a strong foundation. Also today, the company was highlighted in a report explaining how the surge in the recreational cannabis industry can be attributed to the increasing legalization and decriminalization of marijuana across the world.

Sugarmade, Inc. (SGMD) one of the largest publicly traded hydroponics supply companies moving into the industrial hemp space, is a product and brand marketing company investing in products and brands with disruptive potential. Sugarmade’s brands include: ZenHydro.com; CarryOutSupplies.com; and BudLife. Headquartered in Monrovia, California, a city within Los Angeles county, Sugarmade has various business operations in diverse marketplaces including packaging and paper goods for various industries, agricultural supplies.

Sugarmade has expanded into the European hydroponics supply market with a growing base of orders taken through Amazon UK. Over the past few financial quarters, Sugarmade has seen revenue growth patterns expand geographically. As recently as mid-2017, the majority of hydroponic-related revenue growth was seen from California and other West Coast marketplaces, however growth is becoming more geographically dispersed among U.S. states where legalization has eased restriction. This movement into the United Kingdom further expands the base of geographic growth areas for Sugarmade.

Sugarmade recently launched a new corporate initiative in the booming industrial hemp and CBD, committing up to $1 million in capital over the next 12 months to invest in Hempistry, Inc., a privately held Nevada corporation. Hempistry has begun planting an ultra-high cannabidiol (CBD) industrial hemp strain on a land option it holds on 23,000 acres of prime Kentucky farmland. The strain of industrial hemp being grown by Hempistry is ultra-rich in CBD but contains less than 0.3 percent of THC, the psychoactive ingredient found in cannabis. The U.S. hemp industry is expected to produce well over $1 billion in revenues in 2018, with a compound annual growth rate of 14 percent through 2022, according to the Hemp Business Journal.

Demand for industrial hemp and products derived from hemp is soaring, with no let-up in sight, which the company sees as a “tremendous opportunity to become a supplier to this fast-growing sector,” said Chairman and CEO Jimmy Chan, who is also an advisor and minority shareholder of Hempistry.

Sugarmade’s investment into the market for high-CBD hemp is expected to be highly accretive for common shareholders in two ways. First, Sugarmade’s investment will be in the form of common shares in Hempistry allowing Sugarmade common shareholders to possibly benefit from any future initial public offering of Hempistry. Second, Sugarmade is expected to sign a supply agreement with Hempistry for cultivation supplies, which would be additive to corporate revenues.

Sugarmade has also completed a master market agreement with industry leader BizRight Hydroponics, Inc., a leading marketer and manufacturer of cannabis and hydroponic growth supplies, which offers a range of hydroponics-related products including: HPS grow lights, electronic ballasts, HPS bulbs, nutrient mixes, environmental control products, pH measurement and calibration solutions and storage products. BizRight operates the ZenHydro.com website and other e-commerce properties and sells various products to distributors and retailers. BizRight is expected to produce in excess of $30 million in revenues during 2017, with substantial growth expected for 2018.

Sugarmade division CarryOutSupplies.com, the leader in paper and plastic take-out supplies, serves nationwide customers by offering a wide array of high quality products that are cost-efficient, custom-made and delivered on time. This business unit currently serves 2,000 quick service restaurants, garnering from 30-40 percent of the market share. Sugarmade plans to expand operations via the addition of market share and the introduction of new product offerings.

Management

CEO Jimmy Chan is an experienced business executive instrumental in growing multiple business operations with a strong expertise in international trade and banking, and international manufacturing and importation. He is also the founder of CarryOutSupplies.com, a company that revolutionized the custom-printed paper supplies subsector of the quick service restaurant industry, which merged with Sugarmade in 2014.

Arman Tabatabaei serves as operations consultant, providing high-level, day-to-day strategic guidance and tactical operational supervision for all aspects of the corporation’s business. He is an expert at data collection and analysis relative to resource management, risk forecasting and profit and loss management.

Sugarmade specializes in growing and acquiring innovative brands to maximize value for company employees, shareholders and other stakeholders. Sugarmade believes its future is very bright as the company expands operations within the cultivation sector and rapidly increases its revenue base.

Sugarmade, Inc. (SGMD), closed the day's trading session at $0.1069, up 5.01%, on 2,090,134 volume with 215 trades. The average volume for the last 3 months is 2,558,576 and the stock's 52-week low/high is $0.05/$0.43.

Recent News

chart

The Flowr Corporation (TSX.V: FLWR)

The QualityStocks Daily Newsletter would like to spotlight The Flowr Corporation (FLWR).

The Flowr Corporation (TSXV: FLWR), a Canadian Licensed Producer of premium cannabis products, announced today that its Co-founder, Chairman and Chief Strategy Officer, Steve Klein, will share the main stage at MJBizCon, the largest cannabis conference in the world, with Chris Hagedorn, General Manager of Hawthorne Gardening Company,  to discuss the companies’ exclusive R&D alliance.  The session is:

The Flowr Corporation (TSX.V: FLWR), a Health Canada Licensed Producer (LP) of cannabis under the Access to Cannabis for Medical Purposes Regulations (ACMPR), is an emerging Canadian cannabis leader founded by Medreleaf co-founder Tom Flow and a team of industry pioneers, successful start-up executives and top industry scientists. Flowr’s purpose-built cultivation facilities may be the most advanced in the industry, consistently generating high crop yields, delivering premium and ultra-premium cannabis products, and maximizing return on investment. The company also may be an R&D leader as it was selected by the Hawthorne Gardening Division of The Scotts Miracle-Gro Company as its exclusive Canadian cannabis R&D partner.

Flowr’s flagship facility, an 84,000-square-foot campus on seven acres in Kelowna, British Columbia, is engineered to grow premium cannabis in rooms that meet pharmaceutical industry production standards for cleanliness. This, along with exacting protocols designed by the Flowr team, enables Flowr to grow cannabis that meets Health Canada’s stringent standards without treating it with the taste- and smell-killing gamma irradiation that most other producers have to use to clean their product. Irradiating the plant – a process similar to pasteurizing food – impairs many of the important terpenes that provide the positive effects, flavors and scents of cannabis while strengthening unpleasant terpenes. Flowr’s products may deliver a better user experience, thus commanding premium prices.

Flowr’s cultivation facilities, built with proprietary, patent-pending systems, are designed to deliver yields targeted at 450 grams per square foot by the end of 2022, which is three times more efficient than the industry average of approximately 150 grams per square foot. By optimizing yield, the Company may produce significantly more cannabis flower on a smaller footprint than other producers, thus generating far high revenue per square foot and keeping costs much lower, leading to higher margins. The Kelowna facility is presently 20 percent operational with the remaining 80 percent slated to come online by early 2019. It is expected to produce up to 14,000 kg of premium, non-irradiated cannabis flower in 2019. With further enhanced yields and planned expansion of production facilities on the campus, Flowr will reach a total capacity of 60,000 kg annually in 2022.

Leading Flowr’s cultivation program is industry pioneer, company co-founder and Flowr president Tom Flow. Flow is widely recognized for his cannabis thought leadership and expertise building and operating cannabis cultivation facilities. Flow also co-founded MedReleaf and designed, built and set up SOPs for their flagship Marcum cultivation facility. Marcum has continued to be perhaps the most productive facility in the country prior to the Flowr flagship facility. Long one of Canada’s most efficient and profitable LPs, MedReleaf was acquired by Aurora for approximately C$3 billion. Flow and his team have designed and built a total of 17 cultivation facilities and secured three producer’s licenses under various Canadian regulatory regimes.

In March 2018, Flowr and the Hawthorne Gardening Division of The Scotts Miracle-Gro Company – a world leader in lawn and garden products – announced an exclusive strategic R&D alliance. After evaluating numerous Canadian LPs, Hawthorne chose to partner with Flowr based on the experience and expertise of the company’s cultivation and R&D teams and the company’s advanced growing capabilities.

Hawthorne will fund the construction of a 50,000-square-foot R&D facility that is integrated into Flowr’s Kelowna campus. This facility is North America’s first dedicated cannabis R&D facility focused on advancing cultivation techniques and systems. The facility will support researchers from both organizations and combine laboratories, indoor and greenhouse grow suites, training areas and genetics breeding areas in a single building. It is expected to open in early 2019. In addition to helping Flowr maintain its competitive advantage in cultivation, the company’s R&D program will keep it on the cutting edge of cannabis innovation.

Flowr is entering the market with three different brands to meet the growing demand for premium, non-irradiated cannabis in the medicinal and adult use markets:

  • FlowrRx, featuring premium quality medicinal cannabis that enables patients to live better, fuller lives. A dedicated Client Services team will provide patients with personalized support while an R&D team develops innovative flower strains and premium products targeted to specific conditions. Patient well-being is considered at every stage of the process – from genetic selection to harvest, trimming and curing techniques. FlowrRx and its team of passionate scientists and leading cultivation specialists are dedicated to advancing the scientific understanding of cannabis.
  • Flowr is the company’s premium recreational adult-use brand featuring an active, West Coast-inspired lifestyle for the cannabis connoisseur and enthusiast market. Through the continuous innovation of procedures and practices, Flowr’s talented team of experts is crafting premium products that deliver unparalleled experiences.
  • Ace Valley, an exclusive partnership with top-selling Ontario craft beer company Ace Hill, will bring Flowr’s premium product to the millennial and casual adult-use markets under the Ace Valley brand.

Flowr recently signed a Memorandum of Understanding with the British Columbia Liquor Distribution Branch, the province’s sole legal wholesaler of non-medical cannabis, to supply premium and ultra-premium flower to the province’s retail outlets. The company has agreements with several major medical distributors and is in discussions about retail distribution with additional provinces where it believes it can obtain prices commensurate with the quality of the Flowr products. The company is also evaluating other market opportunities including export.

Flowr is poised to become the pre-eminent indoor premium cannabis grower in Canada and one of the country’s top five LPs. The company’s focus on yield, quality and price point and its team’s ability to grow at scale should drive high margins, significant growth and strong return on investment.

The Flowr Corporation (TSX.V: FLWR), closed the day's trading session at $3.65, up 1.39%, on 17,433 volume with 57 trades. The average volume for the last 3 months is 138,379 and the stock's 52-week low/high is $3.11/$8.00.

Recent News

chart

American Premium Water Corp. (HIPH)

The QualityStocks Daily Newsletter would like to spotlight American Premium Water Corp. (HIPH).

American Premium Water Corporation (OTC: HIPH) announces that it's LALPINA CBD beverage will be sold at Come Back Daily (www.comebackdaily.co) in New York, NY. Come Back Daily, located at 381 Broadway, in the TriBeca neighborhood of Manhattan, is New York City's first CBD focused pop up store. This announcement comes after the Company unveiled its wholesale sales strategy that identified the New York market as on its key areas of focus. Also today, CannabisNewsWire released a report highlighting the company which examines the recent news that the incoming government of Andres Manuel Lopez Obrador in Mexico has drafted a bill which is likely to see medical and recreational cannabis legalized once Congress passes it.

American Premium Water Corp. (HIPH), headquartered in Playa Vista, California, is a diversified holding company, manufacturer, distributor and marketer of branded consumer products. HIPH, the acronym for “Hi-Power of Hydro,” maintains a portfolio of subsidiaries catering to the health-conscious consumer and luxury fashion brand connoisseur. The company’s two main pillars focus on the development of health and beauty biotech, dedicated to unlocking the power of hydrogen and nanotechnologies. Paired with cannabidiol or “CBD” in a unique beverage, the technology is proving to be a significant health and wellness option for astute consumers.

Among the company’s holdings are:

  • LALPINA Hydro beverages mix hydrogen with nanotechnology into consumer beverages that combine the best of health, nutrition and fitness to deliver short and long-term therapeutic health benefits. LALPINA Hydro utilizes atomic molecular hydrogen, or diatomic hydrogen, which converts antioxidants in the body to H2O to further enhance hydration, which helps increase endurance, reduce lactic acid and melt away fatigue. Over 500 peer-reviewed articles demonstrate hydrogen to have therapeutic potential in essentially every organ of the human body and in 150 different human disease models.
  • LALPINA Hydro CBD is a technically superior CBD-infused beverage. Using hydro and nanotechnology, LALPINA Hydro CBD encapsulates water molecules with cannabidiol molecules, making them infinitely more bioavailable and accelerating delivery to the body’s cells and tissues. Each bottle of LALPINA Hydro CBD contains 3 million nanograms of CBD free from the psychoactive compound THC (tetrahydrocannabinol). HIPH is the first to introduce a hydro-nano CBD-infused beverage on the market, which is a more effective delivery mechanism for administering CBD into the blood stream than traditional beverages or oils, with up to a 90 percent higher absorption rates.

The company recently signed a distribution agreement for its subsidiary, LALPINA Hydro CBD, to sell its beverages to two SinglePoint, Inc. (OTCQB: SING) e-commerce channels: SingleSeed.com and DIGSHydro.com. SING is a technology and investment company with a portfolio that includes mobile payments, blockchain solutions and ancillary cannabis services. HIPH will drop ship its product to the customers.

HIPH CEO Ryan Fishoff said the e-commerce arrangements “could bring in excess of a million of revenue over the life of the agreement.” The agreement serves as a pillar of the company’s e-commerce distribution strategy, driving awareness and impressions for the LALPINA brand.

In addition, HIPH seeks to market emerging fashion brands and leverage its relationship with classic retail partners while incorporating disruptive blockchain technologies to expand its retail footprint with the following:

  • Gents, a producer of luxury hats and other fine accessories and apparel, was acquired in September 2017. Gents is distributed across many luxury retail outlets including Saks Fifth Avenue, Bloomingdales, Nordstrom, and other high-end channels. The company added the Worthy streetwear brand to its portfolio in June 2018.
  • HIPH also acquired the license to operate the FashionCoinX exchange, a blockchain exchange focused on creating utility tokens for the fashion industry, and created THRD Coin, a multi-branded utility rewards token that is also the first token to be traded on the exchange. The company is leveraging its retail footprint and expertise in the fashion and apparel space with the burgeoning blockchain sector.

American Premium Water Corp. (HIPH), closed the day's trading session at $0.0449, up 9.78%, on 6,727,446 volume with 320 trades. The average volume for the last 3 months is 18,150,854 and the stock's 52-week low/high is $0.0035/$0.1319.

Recent News

chart

DPW Holdings, Inc. (NYSE American: DPW)

The QualityStocks Daily Newsletter would like to spotlight DPW Holdings, Inc. (DPW).

DPW Holdings, Inc. (NYSE American: DPW), a diversified holding company (the “Company”), will announce third quarter 2018 financial results after-market close on Thursday, November 15, 2018.

DPW Holdings, Inc. (NYSE American: DPW), is a diverse holding company pursuing a growth strategy of  acquiring undervalued assets with disruptive technologies with a global impact.

The company invests in diverse industries within the commercial, defense/aerospace, industrial, communication, medical, crypto-mining, hospitality, textile, and corporate investment/lending sectors. DPW has evolved and grown from being a leader in advanced power products. Through its subsidiaries, the company continues to be a leader and supplier of innovative technologies, advanced design and development services, and state-of-the-art power products and solutions.

Through its wholly owned Coolisys Technologies, Inc. subsidiary, DPW is committed to offering world-class technology-based solutions for critical applications and lifesaving services that are primarily driven by innovation. Coolisys targets to the defense, aerospace, naval, homeland security, medical, telecom, datacom and industrial markets. Its growth strategy centers on core markets that are characterized by “high barriers to entry” and require specialized products and services not likely to be commoditized. Through a portfolio of companies, Coolisys is engaged in developing and manufacturing advanced switching power products and power solutions that utilize a customized digital power management and resonant topology to attain:

  • The highest efficiency and highest density power converters and inverters
  • Specialized complex airborne high-frequency, radio frequency (RF), and microwave detector-log video amplifiers (DLVA)
  • Very high-frequency filters
  • Naval power conversion and distribution equipment

Coolisys offers its technology and services through three primary groups: the Power Solutions Group (PSG), the Defense and Aerospace Solutions Group (DSG), and the Advanced Service Industries (ASI) Group. Coolisys manages five divisions:

  • Digital Power Corporation, a leader in providing power electronics technology that is based in northern California.
  • Digital Power Limited dba Gresham Power Ltd, a designer and manufacturer of power distribution systems primarily for Naval use that is based in Salisbury, UK.
  • Microphase Corporation, a designer and manufacturer of microwave electronics technology that is based in Shelton, Connecticut.
  • Power-Plus Technical Distributors, a value-added distributor that is based in Sonora, California.
  • Enertec Systems, a developer and manufacturer of specialized advanced electronic systems for the defense and aerospace sectors that is based in Karmiel, Israel.

DPW’s portfolio of wholly owned subsidiaries also includes Digital Power Lending, LLC (DPL), a California private lending company operating under Financial Lender’s License ##60DBO-77905. DPL is dedicated to strategically providing capital to small and middle-size businesses for an equity interest in addition to loan fees and interest. DPL provides secured and unsecured debt financing for public and private companies. These loans will typically have a six to 12-month maturity and range from $250,000-$5 million. DPL is active in bridge loans, receivable financing, inter company loans and micro loans. DPL will work with a network of company owned ATMs (terminals) in California, which will help utilize its CA Finance Lending License and enable the company to offer micro loans of up to $500 or less.

Management has over 50 years of Wall Street experience of investing in, and building companies. DPL’s desire is to bring world-class companies lending opportunities while allowing main street investors to participate. Deal flow and organization comes from an extensive network of investment bankers, business brokers, family offices, and institutional clients enabling DPL to engage and fund the most compelling companies from Silicon Valley to Wall Street.

To date, DPL has funded over $19 million in loans. Since inception, DPL has internally funded over $15 million to DPW’s portfolio companies and wholly owned subsidiaries. As for companies outside DPW, DPL has lent over $4 million in commercial and real estate loans. DPL has funded INVO Bioscience, Medovex, Parallax, Alzamend Neuro, as well as hospitality clients, such as Guilia DTLA and Prep Kitchens.

Another subsidiary wholly owned by DPW is Super Crypto Mining, Inc., a cloud computing service that provides shared and managed computing resources optimized for various block chain mining solutions. Based in Newport Beach, California, Super Crypto Mining leverages its engineering expertise and existing locations to create cryptocurrency mining facilities throughout the world. The company owns and maintains the computing resources and sells access to their use. The established mining is on the Top 3 crypto-currencies with the goal of having 10,000 miners deployed in 2018. Super Crypto Mining endeavors to leverage its engineering expertise and existing global facilities (high-security defense business locations) to secure mining farms. Super Crypto Mining is a rapidly growing organization that recently strategically secured 25 mega watts to power the company’s mining farm. For crypto currency mining, locations with inexpensive power and secure capacity are minimal and hence costly. Having such a location allows the company to grow its mining business to more than 20,000 mining machines. Super Crypto Mining continues to purchase mining machines and explore opportunities to expand its services into other related areas including mining farm real estate investments, mining machine development, and mainstream blockchain projects.

DPW additionally has beneficiary ownership in MTIX International, Inc., the parent company of MTIX, Ltd. and I.AM, Inc.

MTIX was acquired by Avalanche International aka MTIX International, Inc., in August 2017 and offers “green technology” that uses a proprietary laser process to enhance the surface of textiles. This process reduces water usage by approximately 75 percent, reduces greenhouse gases by approximately 90 percent, and reduces chemical use by approximately 95 percent.

I.AM, acquired in May 2018, owns and operates hospitality offerings that include four Prep Kitchen brand restaurants and Giulia DTLA.

Utilizing a shareholder-centric approach to compensation, DPW has formulated the following 10-year objectives:

  • Achieve compounded annual revenue growth of 25-35%
  • Achieve compounded annual net Income growth of 5%
  • Achieve positive unrestricted free cash flow by the end of 2019

DPW is led by a seasoned team of successful business professionals and entrepreneurs. The company is headquartered in Newport Beach, California.

DPW Holdings, Inc. (DPW), closed the day's trading session at $0.2661, off by 4.66%, on 1,047,408 volume with 1,629 trades. The average volume for the last 3 months is 1,223,978 and the stock's 52-week low/high is $0.243/$5.95.

Recent News

chart

Pressure BioSciences Inc. (PBIO)

The QualityStocks Daily Newsletter would like to spotlight Pressure BioSciences Inc. (PBIO).

Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" and the "Company") today announced that the Company will host a teleconference to discuss its Third Quarter 2018 financial results and to provide a business update. Anyone interested may listen to the teleconference either live (by telephone) or through a replay (by telephone or via a link on the Company's website approximately one day after the teleconference). Also today, company President and CEO, Richard T. Schumacher, was featured in an interview by Stock Day. To hear all of Mr. Schumacher's interview with Stock Day, please go here: http://ibn.fm/E6dK5.

Pressure BioSciences Inc. (PBIO) develops, markets and sells proprietary laboratory instrumentation and associated consumables to the life sciences sample preparation market. Sample preparation refers to the wide range of activities that precede most forms of scientific analysis. It is often complex and time-consuming, yet a critical part of scientific research. The market for sample preparation products is currently estimated at $6 billion worldwide.

The Company’s product line can be used to exquisitely control the sample preparation process. It is based on a patented, enabling technology platform called pressure cycling technology (“PCT”). PCT uses alternating cycles of hydrostatic pressure between ambient (14.5 psi) and ultra-high levels (up to 100,000 psi) to safely and reproducibly control critical biological processes, such as the lysis (breakage) of cells, the digestion of proteins, and the inactivation of pathogens.

Pressure BioSciences’ product line is led by its newly released, next-generation Barocycler 2320EXTREME instrument. Named a finalist in the prestigious 2017 R&D Awards (also known as the “Oscars of Innovation”), the Barocycler 2320EXT is already being touted by some key opinion leaders as an essential element of the $1.8 billion U.S. “Cancer Moonshot” program. For example, Professor Phil Robinson, Co-head of the cancer research center of the Children’s Medical Research Institute (Sydney, Australia), said in a recent interview: “We are collecting the whole proteome on 70,000 tumor samples from all classes where complete clinical outcome is known. Due to its unique capabilities, the Barocycler 2320EXT has become a critical part of our program. It is the primary enabler of the high-throughput component of the project. Without this step, our project simply could not be done. In fact, the Barocycler 2320EXT works so well we have just purchased two more.”

Momentum is building when it comes to the potential for using the Company’s unique PCT technology platform. Leading scientists are intrigued by Pressure BioSciences’ approach, which among other attributes, revolutionizes the process of rupturing cells (lysis) for further study, yielding superior biomolecules for investigation. The Company’s technology transcends current methods of breaking open cells, which use chemicals, blades, metal beads, or other damaging and altering methods that can ultimately adversely affect the result for researchers. Pressure BioSciences’ PCT technology utilizes customized, controlled hydrostatic (water) pressure to rupture cells in a chamber, enabling exquisitely customized levels of pressure to optimally break open different types of cells at prescribed pressure levels—something never before accomplished in a commercial setting. Using this pioneering method, the result is a truer, more legitimate sample, which boosts the efficacy of research and the quality of results. The potential impact of this technology on scientific advancement is enormous, enabling research scientists to begin their studies with biological samples of unprecedented integrity, with the potential to improve research outcomes at the earliest, most critical step. PCT can additionally inactivate pathogens (e.g., viruses, bacteria) using hydrostatic pressure, making the samples safer to study—another innovation with astronomical potential for application in a variety of markets.

The Company’s high-pressure instruments for research purposes are marketed throughout the United States, Europe, China and Japan. To date, Pressure BioSciences has installed nearly 300 PCT Systems in over 165 leading academic, government, biotech and pharma laboratories around the world. Its primary applications are in biomarker discovery, forensics, agriculture and pathology. Over 100 scientific papers have been published on the advantages of the PCT platform, which is also being used in the specialized fields of drug discovery and design, bio-therapeutics characterization, soil and plant biology, vaccine development and histology.

Impressive as their biotech business is, there is more to the PBI story. Pressure BioSciences recently received two patents in China for its novel Ultra Shear Technology (UST), a process that has potential in a wide range of industrial applications, including extending the shelf life of some food products and making two insoluble liquids (like oil in water) soluble. Patents have also been filed in many other countries worldwide. UST is a novel technique based on the use of intense shear forces generated from ultra-high-pressure valve discharge.

This important technology has the potential to play a significant role in a number of commercially important areas through its ability to create high-quality, stable nanoemulsions. Scientific studies indicate that improved absorption, higher bioavailability, greater stability, lower surfactant levels and other advantages can be achieved with nanoemulsions – all hugely important factors in the fields of nutraceuticals, cosmetics, pharmaceuticals, and in various medical products. There is an enormous opportunity in the cannabis market, since the technology can potentially reduce oil droplets containing cannabidiol (CBD) to nanoparticles, after which they can be safely suspended in a stable water solution—something many companies have endeavored to achieve without success. Researchers looking for a way to increase the bioavailability of cannabinoids in the body will find this technology a game changer.

The Company’s UST technology also has possibilities in the production of clean label foods, which are currently processed using several innovative methods, including high-pressure treatments (such as Starbucks’ Evolution line of juices). In 2015, the worldwide market for high-pressure processed (HPP) food was estimated at U.S. $10 billion. UST uses ultra-high pressures and certain valves to generate intense shear forces under controlled temperature conditions to produce nanoemulsions, and which also significantly reduces food-borne pathogens. Pressure BioSciences’ initial focus with this technology will be to evaluate UST for the production of high-quality dairy products and beverages.

Pressure BioSciences Inc. (PBIO), closed the day's trading session at $3.00, even for the day, on 3,915 volume with 10 trades. The average volume for the last 3 months is 2,832 and the stock's 52-week low/high is $2.59/$5.00.

Recent News

chart

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (LXRP).

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) is using its DehydraTECH to increase the quality, taste and effectiveness of cannabis products. Lexaria’s revolutionary drug delivery platform is disrupting the way cannabidiol enters the bloodstream. Rather than relying on the traditional methods of inhalation, which has harmful lasting impact on a person’s health, DehydraTECH allows for a safer, more efficient means of ingestion. Also today, the company was highlighted in an article from FinancialBuzz.com examining how positive political developments as well as growing investment from established corporations are just some of the things that are aiding the marijuana market in its growth.

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) has developed and out-licenses its proprietary technology for improved taste, rapidity, and delivery of bioactive compounds, including cannabinoids. Though boasting a wide range of health benefits, cannabinoids are traditionally poorly absorbed by the body’s gastrointestinal tract. To achieve higher effectiveness, consumers usually default to smoking. Lexaria provides a superior administration method by delivering hemp oil ingredients – or through locally licensed partners, cannabis oil ingredients – through a patented process within food products.

The key differentiator between Lexaria’s products and others on the market is the company’s disruptive technology proven to enhance the absorption of orally ingested cannabinoids while improving the “unusual” taste of cannabinoids and allowing for lower overall dosing with higher efficacy. Lexaria is primarily a B2B enterprise, and is in licensing discussions or has existing agreements with companies in Canada, the largest-market states in the USA, and internationally. Lexaria has also developed its own brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within lipids in popular foods. These brands include ViPova™, Lexaria Energy Foods, and TurboCBD™.

In 2015, Lexaria commissioned an independent, third-party lab to test its technology under carefully monitored in vitro conditions. Results showed that the company’s technological process and lipid formulation both improve intestinal absorption as much as 500%. Additional follow-up studies in human volunteers suggested that Lexaria’s processed, lipid-infused tea may be more effective in an actual gastrointestinal system than in an in vitro simulation with results indicating as much as a 1,000% increase in overall absorption.

Lexaria also has an R&D partnership with the Canadian government’s National Research Council. That R&D is expected to characterize molecular bond formation theorized to occur with Lexaria’s unique technology between the lipid delivery agents and the bioactive substances it processes and combines. Results from this R&D are expected to support accelerating B2B relationships – not just in the cannabis industry, but also to support new B2B business relationships in the fields of vitamins, NSAIDs, and nicotine delivery. All of these sectors expected to offer additional future growth potential.

Aside from testing, a critical component of Lexaria Bioscience’s business model is a strong intellectual property portfolio that utilizes the most commonly used food processing techniques. As of 2017, the company’s patent portfolio includes 19 patent applications filed and pending in more than 40 countries around the world. The most recent patent applications expand Lexaria’s lipophilic food and beverage composition claims to include the processing of cannabinoids, vitamins, NSAIDs and nicotine in many of the world’s most commonly used food processing ingredients. Lexaria is expecting additional new patent awards both in the USA and internationally in 2017 and 2018.

Royalties play a vital role in Lexaria’s revenue-generating business model. The company out-licenses its technology (royalty) to third party partners, and has several deals signed and/or pending. The company’s growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has raised more than $50 million in working capital for the companies he has led over the course of his career. He is supported by a team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods, and other relevant skillsets.

Lexaria Bioscience Corp. (LXRP), closed the day's trading session at $1.25, off by 3.85%, on 186,632 volume with 265 trades. The average volume for the last 3 months is 248,723 and the stock's 52-week low/high is $0.72/$2.54.

Recent News

chart

Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTC: STLHF)

The QualityStocks Daily Newsletter would like to spotlight Standard Lithium Ltd. (OTC: STLHF).

Standard Lithium Ltd. (TSXV: SLL) (OTCQX: STLHF) (FRA: S5L), is pleased to report a maiden lithium resource statement for its 150,000 acre Project in the south-central region of Arkansas, USA (the “Property”; see Company news release 9th May 2018).

Standard Lithium Ltd. (OTC: STLHF) is focused on unlocking the value of existing large-scale U.S.-based lithium brine resources that can quickly be brought into production. The Company believes new lithium production can rapidly be brought on stream by minimizing project risks at selection stage; resource, political & geographic, and regulatory & permitting; and by leveraging advances in lithium extraction technologies and processes.

The Company’s flagship project is in southern Arkansas. The more than 180,000-acre “Smackover Project” is in the most prolific and productive brine processing region in North America. Agreements with large commercial brine operators in the region will allow Standard Lithium to utilize the extensive existing infrastructure, including brine supply and disposal pipelines, water, power and a trained workforce to fast-track project development timelines.

“Arkansas produces about 9.4 billion gallons of brine per year, according to 2010-2016 average statistics reported by the Arkansas Oil & Gas Commission.”

Standard Lithium signed a binding MoU with global specialty chemicals company LANXESS Corporation and its U.S. affiliate Great Lakes Chemical Corporation with the purpose of demonstrating the commercial viability of extraction of lithium from brine (“tail brine”) that is produced as part of LANXESS’ bromine extraction business at its three Southern Arkansas facilities.

LANXESS’ land operations in Southern Arkansas encompass more than 150,000 acres, 10,000 brine leases and surface agreements and 250 miles of pipelines. LANXESS extracts the brine from its wells located throughout the area, and the brine is transported to the three Arkansas plants through a network of pipelines. The three bromine extraction plants currently employ approximately 500 people and process and reinject several hundred thousand barrels of brine per day.

Standard Lithium has developed a breakthrough rapid lithium extraction process that reduces the recovery time of extracting lithium from brine to as little as several hours vs. the current industry method that takes years. The process is also much more environmentally friendly with a significantly smaller footprint than the conventional processes. The company has a signed agreement to locate a demonstration scale lithium extraction plant inside one of LANXESS’ chemical plants in Southern Arkansas.

The Company has also signed an option agreement with NYSE-listed Tetra Technologies for the lithium rights for exploration, extraction, and possible commercial development on approximately 30,000 acres of brine leases in Southern Arkansas. The largest available land package.

Recent laboratory results of four brine samples recovered from two existing wells in Standard Lithium’s project area showed lithium concentrations ranging between 347-461 mg/L lithium, with an average of 450 mg/L lithium in one of the wells and 350 mg/L in the other. Geological modeling of the project area is complete, and a maiden resource report is on the horizon.

Market Opportunity

World demand for lithium continues to surge. The global lithium compounds market is projected to reach U.S. $5.87 billion by 2020 at a compound annual growth rate of 13.22% between 2015 and 2020. Lithium-ion batteries are the fastest growing segment of the market.

Leadership

Standard Lithium’s commitment to being a premier, innovation-driven company focused on developing and commercializing new modern processes for lithium extraction is bolstered by the leading experts that comprise the company’s Scientific Advisory Council. Each member was selected because of their experience and expertise in areas that are central to and/or complement Standard Lithium’s current development plans. Standard Lithium recently welcomed to the Council world-renowned chemist Dr. Barry Sharpless, the recipient of the 2001 Nobel Prize in Chemistry for his work on chirally catalyzed oxidation reactions.

Standard Lithium is led by a team of professionals with proven strong technical and project development skills. CEO Robert Mintak has a global network of industry contacts and is a pioneer in the rapidly evolving lithium space. COO and President Dr. Andy Robinson is an experienced geoscientist with 20+ years of experience and a PhD in Geochemistry from the University of Bristol, UK. Dr. Robinson has worked on a wide range of projects in the resource, power and energy sectors in Europe, Africa, and North and South America.

The company recently appointed Robert Cross as non-executive chairman. Cross is an engineer with 25 years of experience as a financier and company builder in the mining and oil and gas sectors. He co-founded and serves as chairman of B2Gold, a top-performing growing gold producer which is expected to achieve nearly 1 million ounces of low-cost gold production in 2018. He was also co-founder and chairman of Bankers Petroleum Ltd.; co-founder and chairman of Petrodorado Energy Ltd.; and until October 2007 was the non-executive chairman of Northern Orion Resources Inc. He also was previously the chairman and CEO of Yorkton Securities Inc., and a partner in investment banking with Gordon Capital Corp. in Toronto. Cross has an engineering degree from the University of Waterloo (1982) and received an MBA from Harvard in 1987.

Following a multi-million-dollar financing in Q1 2018, Standard Lithium is well-positioned to meet its upcoming milestones including two maiden resource reports and the launch of its breakthrough rapid lithium extraction technology.

Standard Lithium Ltd. (OTC: STLHF), closed the day's trading session at $0.942, off by 2.03%, on 60,073 volume with 42 trades. The average volume for the last 3 months is 52,035 and the stock's 52-week low/high is $0.604/$2.13.

Recent News

chart

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)

The QualityStocks Daily Newsletter would like to spotlight The Green Organic Dutchman (OTC: TGODF).

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF) was highlighted today in a report looking at how drugs have always been the mainstay of treatment for neurological disorders. But another option has gained traction as well: new neurostimulating devices that have been especially helpful in certain movement disorders like Dystonia, Essential Tremor, and Parkinson's Disease. Also today, CannabisNewsWire released a report on the company detailing how TGODF is staking its claim through a focus on organic, sustainably grown cannabis. Additionally, Pot Stock News highlighted the company as one of the cannabis penny stocks to watch moving forward.

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF), whose principal location is in Hamilton, Ontario, produces farm grown, organic, pesticide-free medical cannabis in small batches using all natural, organic craft growing principles. TGOD is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical cannabis. The company carries out its principal activities producing cannabis pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada).

Committed to becoming the global leader in delivering organic cannabis solutions that enhance people’s lives, TGOD consistently adheres to the highest levels of excellence. Its world-class management team includes a proven group of leaders with outstanding executive and operational experience specific to consumer packaged goods, consumer products, cannabis and finance industries.

TGOD is positioned as one of the highest quality and most cost efficient cannabis producers in Canada by leveraging innovative technology and low-cost power solutions. It holds one of the largest land packages under a single ACMPR license in Canada, providing future cannabis Agri-park style development and opportunities for joint ventures, licensing and distribution partners. Its industry leading alliance partners include Eaton, Ledcor Group and Hamilton Utilities Corp.

Eaton is the second largest power management company in the world and promises to supply innovative and cost effective power solutions to meet TGOD’s growing demands. Construction management is supplied by Ledcor, Canada’s second largest multidisciplinary construction company and a pioneer in the Green Building Industry. An alliance with Hamilton Utilities Corp allows TGOD to reduce its power costs from $0.13 per kWh to less than $0.05 per kWh. Greenhouse design is provided by Larssen Greenhouse, whose 25-plus years of experience in building some of the most modern and sophisticated greenhouses in the industry will provide TGOD with state of the art, climate-controlled hybrid greenhouse solutions.

Canada is quickly becoming a hub for cannabis investors with over $1.3 billion raised by Canadian companies to date. There are 58 licensed producers to service a population of 36 million and only two organic producers. TGOD, which holds licenses in Ontario and Quebec, is strategically located in both provinces that together claim 22 million Canadians as residents. Another estimated 57 million people live next door in six U.S. bordering states.

The Canadian cannabis market currently has a massive supply demand gap, which makes TGOD’s expansion plans even more important to investors. These plans include a combined build-out capacity of 970,000 square feet, allowing TGOD to produce 116,000 kg annually of organic cannabis. Upon completion, Phase One in Hamilton, Ontario, which is fully funded, will provide 150,000 square feet of growing capacity capable of producing up to 14,000 kg of cannabis or $112 million in revenue at $8 a gram.

The company’s Quebec expansion will be constructed on a recently secured 75-acre property near Montreal. This new property has a planned expansion of 820,000 square feet capable of producing 102,000 kg of organic cannabis. The first phase of this expansion is underway and construction is expected to be completed by the end of 2018. Quebec’s first phase will consist of 220,000 square feet capable of producing 22,000 kg of cannabis. Two additional expansion phases will add 250,000 square feet (26,000 kg of cannabis) and 350,000 square feet (54,000 kg of cannabis). Power costs remain exceptionally low for both facilities with access to all other needed utilities available and close by.

TGOD also plans to gain a share of the burgeoning cannabis oils market which by Q1 2017 accounted for 49 percent of all cannabis sold in Canada under the ACMPR, up from only 27% in Q2 2016. TGOD has ordered a purpose-built extraction laboratory with an estimated commission in Q4 of 2017. This is a commercial-scale CO2 extraction unit capable of processing up to 12,000 kg of raw material per year and producing approximately $170 million worth of organic cannabis oils. Raw cannabis oil provides a significant downstream manufacturing opportunity into several potential recreational market verticals including edibles, beverages, topicals and concentrates.

Data from the Canadian ACMPR Market Trends report indicates a rising number of consumers will continue to seek out healthier, less conspicuous ways to consume cannabis, ensuring sales of organic cannabis oil products remain brisk. Organic cannabis products demand a significant premium compared to non-organic products and the demand keeps growing.

Plans to take the company public are underway with an initial public offering (IPO) slated for January 2018. In November, the company raised $13 million in equity financing and in March closed a $27 million non-brokered private placement. Another $20 million is currently being raised before the IPO in January, which will be utilized for expansion plans.

TGOD is uniquely positioned between the medical and recreational cannabis industry since Canada is scheduled to legalize cannabis for all adults in mid-2018. As of August 2017, TGOD has 2,400 shareholders. Established in 2012, TGOD’s motto, “Making Life Better,” can be seen in its strategic partnerships, top quality management team, and dedication to organic farming and principles.

To learn more about the company and how to invest, contact TGOD directly at financing@tgod.ca

The Green Organic Dutchman (OTC: TGODF), closed the day's trading session at $2.45, off by 3.92%, on 1,223,271 volume with 1,928 trades. The average volume for the last 3 months is 1,468,578 and the stock's 52-week low/high is $1.87/$7.89.

Recent News

chart

Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF)

The QualityStocks Daily Newsletter would like to spotlight Supreme Cannabis Company Inc. (OTC: SPRWF).

MediPharm Labs Corp. (TSXV: LABS) (the “Company” or “MediPharm Labs”) is pleased to announce that its wholly owned subsidiary MediPharm Labs Inc. (“MediPharm”) has entered into a Cannabis Concentrate Program Agreement (the "Agreement") with The Supreme Cannabis Company, Inc. (TSXV: FIRE) (OTCQX: SPRWF) (FRA: 53S1). Also today, the company announced the release of its financial and operating results for the three months ended September 30, 2018. Among the highlights is news that Q1 2019 revenue for the Company was $5.14 million, a 229% increase from Q1 2018 ($1.56 million) and a 45% increase from the previous quarter ($3.55 million). Additionally, the company was highlighted by Venture Market News, as well as several other publications.  

Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF), is committed to providing premium brands and products that reflect the company’s knowledgeable customers, passionate employees, and culture of innovation. Supreme Cannabis’ mission is to grow the world’s best cannabis and become a leader in the global industry. The company calls its Toronto Venture Exchange stock symbol FIRE “a testament to our passion for cannabis and our obsession with quality.”

Supreme Cannabis believes the world is ready to follow Canada’s lead by ending the 100-year cannabis prohibition and, as Canada’s only coast-to-coast premium cannabis producer, the company sees itself at the center of this global shift.

In August 2018, Supreme Cannabis uplisted its shares to the to OTCQX market in the U.S., where the company trades under the ticker symbol SPRWF. The following month Supreme reported record Q4 revenues of CAD$3.55 million, a 71-percent increase over the previous quarter. Supreme Cannabis also recorded revenue of CAD$8.85 million for its fiscal year ended June 30, 2018, placing it among publicly traded Canadian cannabis companies with the highest reported revenue in their first four quarters of sales.

“As a result of the successful execution of our strategy, we have generated significant revenue growth both for the quarter and the year-end period,” Supreme Cannabis CEO Navdeep Dhaliwal stated in a news release. “We look forward to building on this growth as we expand domestically and internationally.”

The company’s growth strategy includes key industry agreements, such as its CAD$12 million supply agreement with Tilray Inc. (OTC: TLRY), a global leader in cannabis research, cultivation, processing and distribution. The agreement calls for Supreme to supply Tilray with dried cannabis for support of medical cannabis patients in Canada for the period of one year.

Another key component is the company’s wholly owned 7ACRES subsidiary. The 7ACRES cultivation facility, one of the first 40 federally licensed cannabis producers in Canada, is focused on building a core competency in scaled cannabis production, which will give 7ACRES the needed flexibility to maintain leadership in the industry as the Canadian market grows and matures. Though 7ACRES is Supreme Cannabis’ flagship brand and only currently operating business unit, the company will continue to identify new opportunities to grow its portfolio of companies and build innovative cannabis businesses throughout the world.

7ACRES operates from a 342,000-square-foot cultivation facility in Kincardine, Ontario, and has been federally licensed since 2016. Current capacity is 13,333 kilograms dried cannabis annually, with plans to ramp up production by mid-2019 to a rate of 50,000 kilograms per year.

Supreme Cannabis seeks to differentiate 7ACRES from other licensed cannabis producers by producing premium quality product sustainably at scale. “Craft quality, commercial scale” is a slogan the company uses, and the Kincardine greenhouse employs state-of-the-art technology and cultivation best practices to strive toward that goal. Supreme identifies the quality of the 7ACRES product as the company’s primary strength and says a shared “passion for the plant” is the driver of company culture. Six Canadian provinces have signed supply agreements with Supreme, a fact the company credits to the high quality of 7ACRES cannabis.

Its customers, Supreme Cannabis management says, are informed and discerning regarding cannabis, and they value a premium brand that respects their product knowledge. The company believes its high regard for customers, premium product quality, and mass cultivation capability has allowed Supreme Cannabis to emerge as Canada’s preeminent premium cannabis producer. In the Canadian cannabis market, the company has established 7ACRES as a premium brand that’s distributed coast-to-coast and commands premium pricing. The 7ACRES brand is already listed as premium cannabis product in all provinces that disclose their cannabis listing categories, and 7ACRES on average wholesales for up to one-third higher in price than other brands in the Canadian cannabis market.

To further its distribution, in the medical cannabis market Supreme Cannabis has partnered with several Canadian cannabis retailers including Aurora Cannabis, Emerald Health Botanicals, Namaste, Zenabis, and others. The company’s investment portfolio also includes an equity position and long-term global distribution partnership with Medigrow, based in Lesotho, targeting the export of medical cannabis oil for the international market.

Supreme Cannabis seeks to make the company an innovator in the cannabis sector regarding design of cultivation facilities and development of operation excellence metrics. The management team is confident that the 7ACRES flagship brand, the company’s proprietary technology and products, and the company’s culture of passion for cannabis will deliver consistent long-term shareholder value.

Supreme Cannabis Company Inc. (OTC: SPRWF), closed the day's trading session at $1.24, off by 5.33%, on 656,571 volume with 554 trades. The average volume for the last 3 months is 928,707 and the stock's 52-week low/high is $0.95/$2.79.

Recent News

chart

Plus Products Inc. (CSE: PLUS)

The QualityStocks Daily Newsletter would like to spotlight Plus Products Inc. (CSE: PLUS).

Plus Products Inc. (CSE: PLUS) (the “Company” or “Plus Products”) today announced that, according to both BDS Analytics (bdsanalytics.com) and Headset (headset.io) Q3 2018 retail sales data, PLUS™ is the #1 best-selling cannabis-infused edibles brand in California. PLUS™ Sour Watermelon Gummies and PLUS™ Blackberry & Lemon Gummies are the #1 and #2 best-selling branded products, respectively, across all categories in California including flower, vaporizers, edibles, and topicals.

Plus Products Inc. (CSE: PLUS) is a branded cannabis-infused products manufacturer of edibles created to support a healthy and active lifestyle. Headquartered in San Mateo, California, PLUS™ concentrates on producing edibles using extracts to ensure compliant, dosable and delicious products that provide a consistent cannabis experience.

First introduced to the market in 2015 to rave reviews, PLUS™ is now one of the top best-selling edible brands in California. PLUS™ operates through a wholly owned subsidiary, Carberry, and has four cannabis-infused gummy candy SKUs (in addition to limited edition SKUs), that are currently sold in over 200 licensed dispensaries and delivery services. All products under the PLUS™ brand are produced in the company’s 12,000-square-foot food-safe cannabis manufacturing facility in Adelanto, California.

PLUS Products shares are currently listed on the Canadian Securities Exchange. PLUS™ raised CAD$20 million through the offering, for which the lead underwriters were PI Financial and Canaccord Genuity. The company intends to use a portion of the IPO proceeds to fund rapid product capacity expansion, factory automation, working capital and new product development.

Operating in the largest adult-use recreational market in the U.S., PLUS Products holds a temporary manufacturing license in California and was one of the first brands to bring fully compliant products to the legal market. California legalized adult use recreational sales on Jan. 1, 2018, and industry analysts expect edible sales there will continue to amass enviable revenues. According to BDS Analytics, edibles made up 18 percent of marijuana retail sales in February 2018 across licensed retailers in California, with PLUS™ products ranking in the Top 10 of edible brands by retail dollar sales.

During the first half of 2018, PLUS Products generated US$2.45 million in sales, a marked improvement over 2017’s US$1.07 million in sales. The company’s established cannabis products are not only compliant with state laws, they are proving to be extremely popular with consumers. Among the PLUS™ product brands are:

  • Blackberry & Lemon RESTORE, an infusion of carefully dosed cannabis with a 9:1 THC to CBD per gummy.
  • Sour Watermelon UPLIFT, a low-calorie gummy crafted from carefully dosed cannabis with an infusion of 5mg THC per gummy.
  • Pineapple & Coconut CBD RELIEF, a tropical flavor gummy made from pure cannabis-derived CBD that is low-calorie, gluten-free and made with kosher ingredients.
  • Sour Blueberry CREATE, a low-calorie gummy infused with hybrid flower containing 5 mg THC.
  • Limited Edition Rose & Vanilla, available at select locations during Winter 2018, these gummies are crafted with 60 mg THC/30 mg CBD per tin.
  • Limited Edition RAINBOW SORBET gummies was created to celebrate Pride during Spring 2018 with a portion of each purchase donated to The Trevor Project, a confidential suicide hotline for LGBT youth.

“We are extremely proud of the products PLUS has brought to market,” remarked Jake Heimark, CEO and cofounder in a statement. “We’ve quickly grown into one of the leading edible brands in California. With the proceeds of this round, we will continue to further our mission: to make cannabis safe and approachable for all types of consumers.”

The PLUS™ team believes that everyone deserves access to consistent, dosable and delicious cannabis products and strives to make that happen. Producing the best infused products at scale requires thoughtful collaboration among experts in many fields. At PLUS™, our team is comprised of Chefs, Chemists, Food Manufacturing Experts, Engineers, Machinists, Visionaries, Creatives, Strategists and others.

Plus Products Inc. (PLUS), closed the day's trading session at $6.07, off by 6.62%, on 207,630 volume with 265 trades. The average volume for the last 3 months is 333,209 and the stock's 52-week low/high is $3.51/$7.25.

Recent News

chart

Canopy Rivers Inc. (TSX.V: RIV)

The QualityStocks Daily Newsletter would like to spotlight Canopy Rivers Inc. (RIV).

Canopy Rivers Inc. (TSXV: RIV) will report its second quarter fiscal 2019 financial results after markets close on Monday, November 26, 2018. The Company’s unaudited condensed interim financial statements and Management’s Discussion and Analysis for the three and six months ended September 30, 2018 will be available on the Company’s profile on SEDAR at www.sedar.com and in the investors section of the Company’s website at www.canopyrivers.com.

Canopy Rivers Inc. (TSX.V: RIV) is the venture capital investment platform of Canopy Growth Corporation (TSX:WEED, NYSE:CGC).

Canopy Rivers is a unique investment and operating platform structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers collaborates with Canopy Growth to identify strategic counterparties seeking financial and/or operating support. Headquartered in Toronto, Canada, Canopy Rivers has developed an ecosystem of complementary cannabis operating companies operating throughout the cannabis value chain.

Canopy Rivers, in collaboration with Canopy Growth, has established a diverse portfolio of cannabis industry investments that includes domestic and international companies, licensed producers, late-stage licensed producer applicants, pharmaceutical formulators, brand developers and distributors, retail networks, and technology and media platforms. Investments are customized for each counterparty and include a balanced mix of equity, debt, royalty and profit-sharing agreements.

Canopy Rivers’ expanding portfolio includes:

  • Agripharm Corp. (private) is an ACMPR licensed producer, acquired by Canopy Growth in January 2017. In November 2017 Agripharm completed a joint venture with globally recognized partners Green House Seeds and Organa Brands. Canopy Growth has sublicensed proprietary technology, trademarks, genetics, know-how and other intellectual property from Agripharm to distribute the suite of Green House and Organa Brands products across the country, when permissible.
  • CanapaR Corp. (private) owns 80% of CanapaR Italy, a Sicily-based company focused on developing and commercializing Italy’s local hemp cultivation industry through its partnership with the renowned Department of Agriculture at the University of Catania and its rapidly building extraction capabilities for the production of organic CBD oil. CanapaR Italy’s outsource farming model with local Sicilian farmers and its university partnership will provide it with a low-cost source of organic CBD oil, which is increasingly used as an input into new commercial products in the growing health and wellness industries.
  • Civilized Worldwide Inc. (private), is a media and lifestyle brand with offices in New Brunswick and California that embraces and highlights modern cannabis culture. Civilized aims to engage the millions of productive, motivated people who choose to enjoy cannabis responsibly as part of their lifestyle. Reaching 2+ million unique visitors per month, North America-wide, Civilized produces engaging content for and about people who enjoy cannabis responsibly.
  • James E. Wagner Cultivation Ltd. (TSXV:JWCA) was founded in 2007 by third generation agricultural and cannabis cultivators. JWC is the first entirely aeroponic producer of cannabis in Canada, and its patent-pending aeroponic production technology, called GrowthStormTM, allows for perpetual harvesting and improved yields. The company was issued a license to cultivate from Health Canada in January 2017 and a subsequent sales license in March 2018.
  • LiveWell Foods Canada Inc. (TSXV:LVWL) was established in 1993 as a nutritional lifestyle company, and operates in the production of fresh produce and food technology. The company’s O-Hemp division distributes bulk and retail hemp products through its existing channel partners. LiveWell entered into a strategic agreement with Canopy Rivers and Canopy Growth in April 2018.
  • PharmHouse (private) is a joint venture between Canopy Rivers and the principals and operators of leading North American greenhouse produce companies. PharmHouse has arranged to acquire a newly built 1.3-million-square-foot greenhouse located in Leamington, Ontario.
  • Radicle Cannabis Inc. (private) is an ACMPR-licensed cannabis company based in Hamilton, Ontario backed by a management team that brings extensive experience in regulated industries, retail distribution, tobacco and pharmaceutical development, as well as Award-winning cannabis horticulturist breeders and medical professionals.
  • Solo Growth (TSXV:ALZ) is a premiere retail cannabis distributor that will operate locations under the name “YSS by Solo,” relying on the expertise of a management team comprised of founding shareholders, senior officers and board members of Canada’s largest private liquor retailer, Solo Liquor, who collectively have more than 50 years of regulated substance retail experience. Solo Growth was established through a recapitalization of Aldershot Resources Ltd.’s corporate structure that will allow the company to execute a new retail-focused cannabis business strategy as “Solo Growth Corp.”
  • Spot Therapeutics Inc. (private) is an applicant that was acquired by Canopy Growth in August 2017 to solidify its Maritimes expansion strategy and less than four weeks later Canopy Growth signed a supply MOU with the New Brunswick government. Canopy Rivers purchased the property and entered into a long-term lease and committed funding agreement with Canopy Growth.
  • TerrAscend Corp. (CSE:TER) cultivates high-quality cannabis in an indoor hydroponic facility, backed by a strategic investor boasting a strong background in the pharmaceutical space and an extensive portfolio of specialty pharma assets.
  • Vert Mirabel (private) is a joint venture that was established in December 2017 between Canopy Rivers, Canopy Growth, and Les Serres Stephane Bertrand. Bertrand is a large-scale greenhouse operator located in Mirabel, Quebec, and the largest grower of pink tomatoes in the country. With guidance and assistance from Canopy Growth, the greenhouse has been upgraded and retrofitted for cannabis production and was licensed by Health Canada in May 2018.

As the company’s portfolio continues to develop, each constituent benefits from opportunities to collaborate with Canopy Growth and among themselves. Canopy Rivers believes this formula results in an ideal environment for innovation, synergy and value creation for Canopy Rivers, Canopy Growth and across the entire Rivers ecosystem.

Canopy Rivers is led by an experienced team of qualified financial and technical professionals with deep industry experience and relationship networks. The company’s acting CEO and chairman is Bruce Linton, CEO of Canopy Growth and founder of Tweed Marijuana.

Canopy Rivers Inc. (TSX.V: RIV), closed the day's trading session at $3.77, off by 9.16%, on 654,627 volume with 1,147 trades. The average volume for the last 3 months is 469,906 and the stock's 52-week low/high is $3.18/$11.82.

Recent News

chart

United Battery Metals Corp. (CSE: UBM) (OTC: UBMCF) (FWB: 0UL)

The QualityStocks Daily Newsletter would like to spotlight United Battery Metals Corp. (UBMCF).

United Battery Metals Corp. (CSE: UBM, OTC: UBMCF, FWB: 0UL) ("United Battery Metals" or the "Company") wishes to comment on statements from the German Financial Regulator and recent market activity. According to information available to the Federal Financial Supervisory Authority (Bundesanstalt für Finanzdienstleistungsaufsicht - BaFin), buy recommendations are currently being issued for shares in United Battery Metals Corp. (ISIN: CA9095801028) on a large scale via e-mail newsletters.

United Battery Metals Corp. (CSE: UBM) (OTC: UBMCF) (FWB: 0UL) is a vanadium exploration company focused on becoming the first vanadium producer in North America. The company’s flagship project is the Wray Mesa Project, an exploration-stage vanadium property located in Montrose County, Colorado. The property consists of over 107 contiguous mining claims on about 3000 acres. United Battery Metals recently announced that it has tripled its vanadium rich land package in Colorado and Utah. The claims are located on land where both the surface and mineral ownership is held by the Bureau of Land Management (BLM) of the U.S. Department of Interior. Valid unpatented mining claims grant the holder the right of mineral possession as allowed by the General Mining Law of 1872, subject to the various state and federal rules and regulations pertaining to mineral exploitation.

Global demand for vanadium as a strategic metal has exploded in recent years. Vanadium price surges have hit recent highs of approximately $22.63 per pound from about $9 per pound last year.? As a result, mining companies are returning to exploration efforts for vanadium.

The Wray Mesa Project area is part of the La Sal Creek District, which has a long history of exploration and production efforts with records showing drill exploration likely started there in the late 1940s with geologists from the U.S. Geological Survey (USGS) and the Atomic Energy Commission, then continued from the 1960s through the 1980s with private sector interests involved. Based on historical records, the Wray Mesa Project appears to have very good to excellent potential with an inferred resource of 500,000 pounds of uranium- and a current estimated vanadium resource of 2,640,000 pounds as per the last 43-101 prepared in 2013 by Anthony Adkins who is a qualified geologist.

The world’s vanadium demand is set to increase significantly as China implements tighter controls over this critical element as it is used in infrastructure to strengthen steel. With trade war tensions mounting, the U.S. will likely be in dire need of a domestic supply of vanadium for use in steel plants opening nationwide and grid power storage. In fact, the White House has deemed vanadium one of 35 critical elements to United States national and economic security (USGS). US Steel announced additional plants opening nationwide, and this bull market in domestic steel production is likely to increase the demand for a domestic source of vanadium as China has begun restricting vanadium exports to the U.S. amid mounting tensions between the two countries over tariffs and certain critical elements such vanadium.

UBM utilized resource estimation software to model the mineralization detected in a number of the 715 historical and 24 recent drill holes within the project area. Results of the model run, minus the estimated effects of the historic mining, identify an indicated resource of approximately 85,500 short tons at an average grade of 0.16% eU308 for a total of 271,000 pounds of contained uranium. Inferred resources total 57,400 short tons at an average grade of 0.15% of eU308 for a total of about 169,000 pounds of contained uranium. The vanadium resource for the two categories, based on a conservative V:U ratio of 6:1, is 1,626,000 (O.95% average grade) and 1,014,000 (0.88% average grade) pounds, respectively.

Vanadium has multiple uses in modern society including being used in vanadium redox flow batteries (“VRFBs”), car charging stations, nuclear power plants and in steel manufacturing. An article in Mining.com notes that vanadium pentoxide (V2O5), which is used in the production of VRFBs used in energy storage systems, breached US$20 a pound in September 2018 for the first time since 2005, a four-fold increase from the start of 2017.

California recently announced that all homes and mid rises must install solar panels by 2020. Vanadium redox flow batteries (VRFBs) are by far the most superior batteries for large scale energy storage systems and the reason why the Vanadium Redox Flow batteries will dwarf the lithium battery demand. California was the first to announce this green initiative and many experts expect that the revolution will be implemented nationwide in the near future.

Vanadium is one of the 35 minerals deemed critical to the national security and economy of the United States. Among the important uses of vanadium are the following:

  • Fast-charging VRFBs have unique characteristics making them especially attractive when compared to conventional batteries. VRFBs can operate at any temperature, be charged and discharged at the same time, have greater design flexibility and a 25-plus year lifecycle. VRFB’s promise to be a major player in the green energy storage revolution because they are 100 percent reusable, recyclable, are nonflammable, compact, able to provide large grid energy storage, can be fully contained and are seen as a viable alternative to lithium-ion batteries.
  • VRFBs can be used in a variety of energy storage applications including microgrids, during peak shaving periods and for load leveling, as an uninterruptible power supply, for wind and solar farms, and as an off-grid power supply.
  • Approximately 85 percent of vanadium produced is used as ferrovanadium or as an additive to strengthen and harden steel used for applications in axles, crankshafts, gears, surgical instruments and tools, knives, jet engines, high-speed airframes, dental implants, and in seamless tubing for the aerospace, defense and bicycle industries.
  • Vanadium alloys are used in nuclear reactors because of the metal’s low neutron-absorbing properties.

The management team at United Battery Metals Corp. includes president, CEO and Director Matthew Rhoades, the former State Geologist for New Mexico and an accomplished professional geologist with direct working experience in exploration and development projects at numerous deposits and mines throughout the American West, Canada, Mexico and South America. He is joined by George Sharpe, a qualified Mineral Exploration Geoscientist, QP, MCIM and CGT, with over 23 years of global mineral exploration in iron coal, gold, base metals, rare earths, uranium, PGE’s, diamonds, iron and industrial minerals.

United Battery Metals Corp. (UBMCF), closed the day's trading session at $0.9075, off by 29.05%, on 940,598 volume with 889 trades. The average volume for the last 3 months is 110,971 and the stock's 52-week low/high is $0.649/$1.58.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.